22-26 September 2021 Virtual Conference
![]() |
![]() |
![]() |
![]() |
P2-001 | Circadian rhythm of salivary cortisol and cortisone in school-aged children born very preterm and adequate for gestational age | Gonzalo Dominguez-Menendez | ![]() |
![]() |
|||
P1-001 | Optimizing the timing of highest hydrocortisone dose in children and adolescents with 21-hydroxylase deficiency | Mariska Schrder | ![]() |
![]() |
|||
P1-002 | Adrenocortical hormone profiles do not predict the molecular etiology in non-CAH primary adrenal insufficiency | Tuba Seven Menevse | ![]() |
![]() |
|||
P2-002 | How do urine steroid metabolites of spot samples correlate with 24 hour urine specimens in children with congenital adrenal hyperplasia? | Grit Sommer | ![]() |
![]() |
|||
P1-003 | Growth-Related Characteristics of Patients 18 Years of Age with Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency (21OHD): Real-World Evidence from the I-CAH Registry | Mallory Farrar | ![]() |
![]() |
|||
P2-003 | Endocrine-disrupting chemicals: an often-forgotten etiology of endocrinological disturbances | Júlia Galhardo | ![]() |
![]() |
|||
P2-004 | SERUM SEX HORMONE BINDING GLOBULIN LEVELS, BUT NOT 4-HOUR PROFILE OF 17-OH PROGESTERONE, WOULD BE USEFUL IN MONITORING CHILDREN WITH CONGENITAL ADRENAL HYPERPLASIA | Ozge Besci | ![]() |
![]() |
|||
P1-004 | Depression among insured children and young adults in the United States with congenital adrenal hyperplasia | Lauren Harasymiw | ![]() |
![]() |
|||
P2-005 | Glucocorticoid side-effects in Duchenne Muscular Dystrophy: Systematic review of side effects in published literature and a survey of the concerns of the patient community | Caleb Hariri | ![]() |
![]() |
|||
P1-005 | Alterations in resting-state functional connectivity in patients with congenital adrenal hyperplasia | Valeria Messina | ![]() |
![]() |
|||
P2-006 | Single centre experience of Hydrocortisone Granules (Alkindi) in children under 6 years of age with Adrenal Insufficiency | Claire Snow | ![]() |
![]() |
|||
P1-006 | International practice of therapy monitoring in congenital adrenal hyperplasia Real World data from the I-CAH registry | Neil Lawrence | ![]() |
![]() |
|||
P2-007 | Emotion regulation in congenital adrenal hyperplasia | Annelies vant Westeinde | ![]() |
![]() |
|||
P1-007 | Brain activity during working memory in congenital adrenal hyperplasia | Annelies vant Westeinde | ![]() |
![]() |
|||
P2-008 | High-dose steroids in the management of Paediatric Multisystem Inflammatory Syndrome Temporally associated with SARS-CoV-2 (PIMS-TS): Considering the hypothalamic-pituitary-adrenal axis | Sinead McGlacken-Byrne | ![]() |
![]() |
|||
P1-008 | Long-term Cardiometabolic Morbidity In Young Adults With Classic 21-Hydroxylase Deficiency Congenital Adrenal Hyperplasia | Beatrice Righi | ![]() |
![]() |
|||
P1-009 | Backdoor Pathway hormones and 11-oxygenated Androgens are elevated in Patients with 21-hydroxylase deficiency | Alexandra Kulle | ![]() |
![]() |
|||
P2-009 | Variability of advice and education for steroid sick day dosing in Duchenne Muscular Dystrophy and the impact of the COVID-19 pandemic: Results of a UK wide patient survey | Sze Choong Wong | ![]() |
![]() |
|||
P1-010 | Glucose regulation in children with primary adrenal insufficiency: preliminary data. | Julie Park | ![]() |
![]() |
|||
P2-010 | Clinical characteristics of cytochrome P450 oxidoreductase deficiency: a nationwide survey in Japan | Shuichi Yatsuga | ![]() |
![]() |
|||
P2-011 | Rare Presentation of Adrenal Insufficiency in an Infant with Holocarboxylase Synthetase Deficiency | Aws Al-Farsi | ![]() |
![]() |
|||
P1-011 | Bone and endocrine monitoring in boys with Duchenne Muscular Dystrophy | Sze Choong Wong | ![]() |
![]() |
|||
P1-012 | Real-world clinical profiles of children with hypophosphatasia (HPP) from the Global HPP Registry | Gabriel Martos-Moreno | ![]() |
![]() |
|||
P2-012 | Defective Cortisol Secretion in Response to Spontaneous Hypoglycemia but Normal Cortisol Response to ACTH stimulation in neonates with Hyperinsulinemic Hypoglycemia (HH). | Shayma Ahmed | ![]() |
![]() |
|||
P1-013 | Characterisation and phenotype-genotype associations of a large cohort of patients with pseudohypoparathyroidism type 1A and 1B | Philippa Prentice | ![]() |
![]() |
|||
P2-013 | Utilisation Of The I-CAH Registry As A Tool For Facilitating Health Quality Improvement Strategies- Results Of An International Survey Of Specialist Centres | Salma Ali | ![]() |
![]() |
|||
P1-014 | Tumor induced osteomalacia, a rare and complex condition with more treatment options, exemplified in two patients. | Niels Birkebk | ![]() |
![]() |
|||
P2-014 | Clinical and hormonal evolution of aldosterone synthase deficiency: Is complete remission possible? | Busra Gurpinar Tosun | ![]() |
![]() |
|||
P2-015 | Clinical and metabolic characteristics of hyperandrogenic girls with non-classic congenital adrenal hyperplasia and polycystic ovary syndrome | Teodora Karamfilova | ![]() |
![]() |
|||
P1-015 | Vitamin D status and recommendations in Paediatric Inflammatory Multisystem Syndrome Temporarily associated with SARS-CoV-2 (PIMS-TS) | James Robert Brighouse | ![]() |
![]() |
|||
P2-016 | Rapid clearance of hydrocortisone as a cause of poor control of CAH detected by 24-hour profiling of hydrocortisone concentrations. | Aikaterini Iordanidou | ![]() |
![]() |
|||
P1-016 | Leptin to adiponectin ratio at the age of 12 is negatively associated with lumbar spine bone mineral apparent density independently of body fat mass in 18-year old males. | Vallo Tillmann | ![]() |
![]() |
|||
P2-017 | A PROSPECTIVE STUDY OF CHILDREN 0-8 YEARS WITH CONGENITAL ADRENAL HYPERPLASIA AND ADRENAL INSUFFICIENCY ON TREATMENT WITH HYDROCORTISONE GRANULES MONITORED BY 17-OHP SALIVA SAMPLING | Uta Neumann | ![]() |
![]() |
|||
P1-017 | Clinical Spectrum of Hypomagnesemia type 1 (HOMG1) due to Novel TRPM6 mutations | Sommayya Aftab | ![]() |
![]() |
|||
P1-018 | A rare cause of hypercalcemia: Congenital Lactase Deficiency | Mehmet Eltan | ![]() |
![]() |
|||
P2-018 | Cushings disease treatment results correlation with pituitary MRI in children | Eda Yanar | ![]() |
![]() |
|||
P1-019 | Acetazolamide treatment in a patient with pseudohypoparathyroidism with venous calcification | Tuba Seven Menevse | ![]() |
![]() |
|||
P2-019 | Genetic analysis of paediatric primary adrenal insufficiency of unknown aetiology over 25 years | federica buonocore | ![]() |
![]() |
|||
P2-020 | Panhypopituitarism after treatment procedures in pituitary-hypothalamic area a single center experience | Yuliya Bazdarska | ![]() |
![]() |
|||
P1-020 | A novel TRPM6 variant (c.3179TA) causing familial hypomagnesemia with secondary hypocalcemia | Meghna Chawla | ![]() |
![]() |
|||
P2-021 | The reliability of Salivary Cortisol compared to Serum Cortisol for diagnosing adrenal insufficiency in the gold standard ACTH stimulation test in children | Silvia Ciancia | ![]() |
![]() |
|||
P1-021 | Incidence of Type 1 Diabetes in Children and Adolescents during the Covid-19 Pandemic in Germany: Results from the DPV registry | Clemens Kamrath | ![]() |
![]() |
|||
P2-022 | Prevalence of adrenal insufficiency (AI) requiring treatment with hydrocortisone in children tested with the LDSST | Julie Park | ![]() |
![]() |
|||
P1-023 | Capillary blood sample collection at home for HbA1c measurements during the COVID-19 pandemic in children with diabetes mellitus | Rachel Qian Hui Lim | ![]() |
![]() |
|||
P2-023 | Serum cortisol and cortisone, and urinary cortisol, cortisone, and tetrahydro-metabolites concentrations in school-aged children born very preterm adequate for gestational age | Gonzalo Dominguez-Menendez | ![]() |
![]() |
|||
P1-024 | Resolution of feeding problems in patients with congenital hyperinsulinism | Chris Worth | ![]() |
![]() |
|||
P2-024 | The incidence and presentation of congenital adrenal hyperplasia in an unscreened population | Tracey Anne Conlon | ![]() |
![]() |
|||
P1-025 | Longitudinal Auxological Recovery and Reduced Neurodevelopmental Problems in Hyperinsulinaemic Hypoglycaemia | Chris Worth | ![]() |
![]() |
|||
P2-025 | Genotypic Sex and Severity of the Disease Determine the Time of Clinical Presentation in Steroid 17a-Hydroxylase/17,20-Lyase Deficiency | Erdal Kurnaz | ![]() |
![]() |
|||
P1-026 | Efficacy and Tolerability of GLP-1 Receptor Agonists in Children and Adolescents with Obesity | Paul MacDaragh Ryan | ![]() |
![]() |
|||
P2-026 | Testicular adrenal rest tumour in children with classical congenital adrenal hyperplasia: A case series. | Hooi Peng Cheng | ![]() |
![]() |
|||
P1-027 | The SARS-CoV-2 Pandemic Is Associated With Increased Severity Of Presentation Of Childhood Onset Type 1 Diabetes Mellitus: A Multicentre Study Of The First COVID-19 Wave | Sinead McGlacken-Byrne | ![]() |
![]() |
|||
P2-027 | High doses op-DDD cause metrorragia in young girls | Cecile Thomas-Teinturier | ![]() |
![]() |
|||
P2-028 | An Adolescent Case With Adrenoleukodystrophy Diagnosed After Detection Of Leydig Cell Dysfunction | Iclal Okur | ![]() |
![]() |
|||
P1-029 | Incidence and severity of new-onset paediatric Type 1 diabetes in the COVID-19 pandemic a UK multicentre perspective | Sophia Sakka | ![]() |
![]() |
|||
P2-029 | FLUDROCORTISONE IS THE SALVAGE TREATMENT IN CASES WITH CALCINEURIN INHIBITOR RELATED HYPERKALEMIA | Yagmur Unsal | ![]() |
![]() |
|||
P2-030 | Development of a novel weight-based steroid emergency plan for patients with Duchenne Muscular Dystrophy | Sally Tollerfield | ![]() |
![]() |
|||
P1-030 | Metabolic Control and Health-Related Quality of Life in Children with Diabetes Mellitus during the COVID-19 Pandemic: Results from a Prospective Swiss Cohort Study | Serpil Vural | ![]() |
![]() |
|||
P1-031 | Efficacy and Safety of Setmelanotide in Individuals With Obesity Due to POMC or LEPR Deficiency: Phase 3 Results From Pivotal and Supplemental Cohorts | Kristi ODonovan | ![]() |
![]() |
|||
P2-031 | Investigation of usage and acceptance of hydrocortisone granules in capsules for opening in children with adrenal insufficiency | Uta Neumann | ![]() |
![]() |
|||
P2-032 | Congenital Adrenal Hyperplasia caused by homozygous pathogenic variant in the HSD3B2 gene. | Eirini Fylaktou | ![]() |
![]() |
|||
P1-032 | Sex hormones drive changes in lipoprotein profiles in adolescents; early implications for cardiovascular disease risk | George Robinson | ![]() |
![]() |
|||
P1-033 | Metabolomics in early life and the association with body composition at age 2 years | Inge van Beijsterveldt | ![]() |
![]() |
|||
P2-033 | Congenital Adrenal Hyperplasia with a CYP21A2 deletion overlapping Tenascin-X gene | Catarina Rodrigues Ivo | ![]() |
![]() |
|||
P2-034 | Maternal primary adrenal cortex insufficiency during pregnancy: Spotlight on the Fetus and the Neonate. A systematic review and meta-analysis. | Georgia Ilia | ![]() |
![]() |
|||
P1-035 | The possible association of the apoptotic marker APO1/Fas with predisposition to metabolic syndrome and mean platelet volume in children | Eirini Kostopoulou | ![]() |
![]() |
|||
P2-035 | Assessment of blood pressure and carotid intima media thickness (CIMT) in children with primary adrenal insufficiency | Julie Park | ![]() |
![]() |
|||
P1-036 | Reversal of metabolic derangement in patient with congenital generalized lipodystrophy treated with metreleptin | Jamal Aljubeh | ![]() |
![]() |
|||
P2-036 | Challenges in diagnosis and treatment of Cushing Disease in a 12 years old boy | Agim Gjikopulli | ![]() |
![]() |
|||
P1-037 | The effect of trans-palmitoleic acid on lipid accumulation and the fatty acid synthase gene expression in hepatocytes | Mitra Nourbakhsh | ![]() |
![]() |
|||
P2-037 | Congenital Adrenal Hyperplasia caused by compound heterozygosity of two novel CYP11B1 gene variants. | Eirini Fylaktou | ![]() |
![]() |
|||
P1-038 | Are Serum Spexin Levels Associated With Metabolic Syndrome Antecedents In Obese Adolescents? | Ahmet Uar | ![]() |
![]() |
|||
P2-038 | Addisons disease: Delay in diagnosis in a girl with longstanding symptoms | Myrto Bonataki | ![]() |
![]() |
|||
P2-039 | Clinical spectrum of congenital adrenal hyperplasia due to 3 beta hydroxysteroid dehydrogenase deficiency ;A case series | Tahir Shaheen | ![]() |
![]() |
|||
P1-039 | Serum endocan as a predictive biomarker of cardiovascular risk in obese pediatric patients | Selenia Curatola | ![]() |
![]() |
|||
P1-040 | Liraglutide for the Management of Childhood Obesity | Louise Apperley | ![]() |
![]() |
|||
P2-040 | Retrospective Evaluation of Cases Diagnosed with Classical Congenital Adrenal Hyperplasia Due to 21 Hydroxylase Deficiency | elmaogullari Selin | ![]() |
![]() |
|||
P2-041 | CORTICOTROPIN-INDEPENDENT CUSHING SYNDROME IN TODDLERHOOD: A CHALLENGING DIAGNOSIS AND TREATMENT | Julia Galhardo | ![]() |
![]() |
|||
P1-041 | Phenotypic Characteristics of Patients with 45,X/46,XY Mosaicism: Growth, Gonadal Pathology and Tumour Risk | Sukran Poyrazoglu | ![]() |
![]() |
|||
P2-042 | A case of adrenal insufficiency during the course of multisystem inflammatory syndrome in children (MIS-C) | Fatih Kilci | ![]() |
![]() |
|||
P1-042 | Disorders of sex development: clinical and genetic heterogeneity | Irina Nikitina | ![]() |
![]() |
|||
P2-043 | Aetiology and different clinical conditions of primary adrenal insuffiency in a region of North Africa | Fadila Bouferoua | ![]() |
![]() |
|||
P1-043 | Broad range of phenotypes in an international cohort of 75 DSD individuals with SF-1/NR5A1 variants | Chrysanthi Kouri | ![]() |
![]() |
|||
P1-044 | Adolescents and young adult men with non-syndromic hypospadias: testicular function and in-depth genetic screening | Lloyd Tack | ![]() |
![]() |
|||
P2-044 | Clinical and evolutionary aspects of Allgrove Syndrome, Algerian experience | Bouferoua Fadila | ![]() |
![]() |
|||
P1-045 | Bilateral testicular regression: etiology and outcome in a large Belgian series | Lloyd Tack | ![]() |
![]() |
|||
P2-045 | A Rare Coexistence of two autosomal recessive conditions: Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency (CYP21A2 mutation) with Beta Thalassemia Major | Aniqa Aslam | ![]() |
![]() |
|||
P1-046 | Endocrine & Molecular Genetic Findings In XY Boys Investigated For A Disorder Of Sex Development: The Glasgow Experience | Malika Alimussina | ![]() |
![]() |
|||
P2-046 | X- linked Adrenoleukodystrophy in southern of Tunisia | Sana Kmiha | ![]() |
![]() |
|||
P2-047 | Clinical, biological and genetic aspects of congenital adrenal hyperplasia in children at the Central Hospital of Army in Algiers | Malek Iabbassen | ![]() |
![]() |
|||
P1-047 | STK11 gene variant (Peutz-Jeghers Syndrome) presenting with unilateral pre-pubertal gynaecomastia and macro-orchidism without muco-cutaneous pigmentation or gastrointestinal symptoms. | Meera Shaunak | ![]() |
![]() |
|||
P2-048 | Coexistence of Adrenal Insufficiency and Hypergonadotropic Hypogonadism: P450scc Deficiency | Merve Sakar | ![]() |
![]() |
|||
P1-048 | Gonadal Outcome in 17beta-HSD deficiency and 5alpha-reductase deficiency | Lidewij S Boogers | ![]() |
![]() |
|||
P2-049 | Assessment of Patients With Congenital Adrenal Hyperplasia in Armenia | Renata Markosyan | ![]() |
![]() |
|||
P1-049 | Biallelic PPP2R3C mutations are associated with partial and complete gonadal dysgenesis in 46,XY and 46,XX individuals | Tulay Guran | ![]() |
![]() |
|||
P1-050 | Pathogenic variants in the human m6A reader YTHDC2 are associated with primary ovarian insufficiency | Sinead McGlacken-Byrne | ![]() |
![]() |
|||
P2-050 | First case in Lebanon of homozygous mutation in CYP 11B2 leading to isolated aldosterone deficiency. | Ahlam Azar | ![]() |
![]() |
|||
P2-051 | A Rare Cause of Hyponatremia in a Child with Hirschsprung Disease Operated with an Ileostomy | Abeer Alassaf | ![]() |
![]() |
|||
P1-051 | A Global Natural History Study (NHS) of Fibrodysplasia Ossificans Progressiva (FOP): Normal Long Bone Growth and Abnormalities in Younger Patients over 36 Months | Will Cherry | ![]() |
![]() |
|||
P1-052 | Impact of Vertebral Fracture on Auxological Profile and Insulin-like Growth Factors of Children after Acute Lymphoblastic Leukemia Treatment | Moon Bae Ahn | ![]() |
![]() |
|||
P1-053 | Growth and Puberty in Patients with Osteogenesis Imperfecta | Ay&351;e p&305;nar ztrk | ![]() |
![]() |
|||
P2-053 | Mutation of NROB1 and Double mutants in cis of CYP21A2 gene in a Chinese boy with primary adrenal insufficiency | Huamei Ma | ![]() |
![]() |
|||
P1-054 | Decreased bone mineral density in children receiving long-term anticoagulation is associated with pubertal development | Adalbert Raimann | ![]() |
![]() |
|||
P2-055 | Twin infants with salt-wasting: double the trouble | Ana Graneiro | ![]() |
![]() |
|||
P1-055 | Premature epiphyseal fusion induced by a retinoic acid agonist in a young girl with fibrodysplasia ossificans progressiva | Sigrún Hallgrímsdóttir | ![]() |
![]() |
|||
P2-056 | Effect of treatment of double precocious puberty in a 9-year-old girl- case report | Beata Sawicka | ![]() |
![]() |
|||
P1-056 | Chondrocyte regulating and other growth plate genes are invaluable growth regulators: a study on children with short stature from 55 consanguineous families | Shenali Anne Amaratunga | ![]() |
![]() |
|||
P1-057 | High rate of positive genetic findings in children born small for gestational age with persistent short stature (SGA-SS): Growth plate genes as key regulators of intrauterine growth | Ledjona Toni | ![]() |
![]() |
|||
P2-057 | Classical Congenital adrenal hyperplasia: about 7 cases | najat draoui | ![]() |
![]() |
|||
P1-058 | AAV liver gene therapy-mediated inhibition of FGF23 signaling as a therapeutic strategy for X-linked hypophosphatemia | Volha Zhukouskaya | ![]() |
![]() |
|||
P2-058 | Denosumab therapy for giant cell granuloma in a paediatric patient: using quantification of Tc99m-MDP uptake on SPECT imaging to guide treatment. | Laura Wade | ![]() |
![]() |
|||
P2-059 | Vertebral compression and shape in children with osteogenesis imperfecta on regular Zoledronic acid infusions | Alaa Baioumi | ![]() |
![]() |
|||
P1-059 | Cartilage -specific knockout of SIRT1 significantly reduces bone quality and catch-up growth efficiency | Galia Gat-Yablonski | ![]() |
![]() |
|||
P2-060 | Osteosclerotic Metaphyseal Dysplasia: A novel homozygous LRRK1 mutation in two siblings | Chariklia Pieridou | ![]() |
![]() |
|||
P1-060 | Mosaic PHEX variants are important causes of X-linked hypophosphataemic rickets. | Philippa Prentice | ![]() |
![]() |
|||
P2-061 | Experience of 6-months of burosumab therapy in five siblings with X-linked hypophosphataemic rickets in the State of Kuwait | Sameer Al Shammari | ![]() |
![]() |
|||
P1-061 | Clustering of Hypoglycaemia Events in Patients with Hyperinsulinism (HI): Extension of the Digital Phenotype | Chris Worth | ![]() |
![]() |
|||
P1-062 | Epidemiology of type 1 diabetes in children and adolescents: a 50-year, single center experience | Dogus Vuralli Karaoglan | ![]() |
![]() |
|||
P2-062 | Severe Hypophosphatemic Rickets due to Tumor-Induced Osteomalasia | Belma Haliloglu | ![]() |
![]() |
|||
P1-063 | Comparison of triglyceride and glucose index and homeostatic model assessment for insulin resistance in children and adolescents with type 2 diabetes mellitus | Jong Seo Yoon | ![]() |
![]() |
|||
P2-063 | Diagnostic Challenges of Vitamin D-Dependent Rickets Type 1A (VDDR1A) caused by CYP27B1 mutation in Resource Limited Countries: A Case Series from Three families | Sommayya Aftab | ![]() |
![]() |
|||
P2-064 | Lack of Cinacalcet response in Neonatal Severe Hyperparathyroidism (NSHPT) due to homozygous CASR mutation | Ammar Haider | ![]() |
![]() |
|||
P1-064 | Initial Neutrophil/Lymphocyte and Lymphocyte/Monocyte Ratios Can Predict Future Insulin Need in Newly Diagnosed Type 1 Diabetes Mellitus | Ibrahim Mert Erbas | ![]() |
![]() |
|||
P1-065 | Efficacy of use of Continuous Glucose Monitoring System in patients with Congenital Hyperinsulinism | Yesica Tropeano | ![]() |
![]() |
|||
P2-065 | Is conventional treatment still the first choice in pediatric patients with PHEX mutations in an era of monoclonal FGF-23 antibody? | Yagmur Unsal | ![]() |
![]() |
|||
P1-066 | Mortality in children with monogenic diabetes | Eugenia Globa | ![]() |
![]() |
|||
P2-066 | Vosoritide Clinical Study Data Demonstrates CXM is a Superior Biomarker of Endochondral Bone Growth | Kevin Larimore | ![]() |
![]() |
|||
P1-067 | The Molecular Genetic Etiology by Whole Exome Sequence Analysis in Cases With Familial Type 1 Diabetes Mellitus without HLA Haplotype Predisposition or Incomplete Predisposition | ferda evin | ![]() |
![]() |
|||
P1-068 | Birth weight and diazoxide unresponsiveness strongly predict the likelihood of congenital hyperinsulinism due to a mutation in ABCC8 or KCNJ11 | Thomas Hewat | ![]() |
![]() |
|||
P1-069 | Oxidized lipid-associated protein damage in children and adolescents with type 1 diabetes mellitus: new diagnostic/prognostic clinical markers. | Eirini Kostopoulou | ![]() |
![]() |
|||
P2-069 | Evaluation of Admission Characteristics, Treatment and Follow-up Findings of Children with Primary Osteoporosis | Sirmen Kizilcan Cetin | ![]() |
![]() |
|||
P1-070 | Change in HbA1C predicts future abnormal Oral Glucose Tolerance Tests in children and adolescents with Cystic Fibrosis. | Sommayya Aftab | ![]() |
![]() |
|||
P2-070 | Phenotype characterization of a PHEX intron mutation in an Italian family affected by X linked hypoposphatemic rickets. | Francesca Aiello | ![]() |
![]() |
|||
P1-071 | Morning salivary cortisol and stress response in term and preterm infants hospitalized in the intensive care unit. | Marta Olszewska | ![]() |
![]() |
|||
P1-072 | Clinical characteristics of children with Congenital Hyperinsulinism: Results from the European Registries for Rare Endocrine Conditions (EuRRECa) Project | Lukas Plachy | ![]() |
![]() |
|||
P2-072 | ACAN GENE SKELETAL DYSPLASIA (SHORT SIZE SYNDROME, WITH OR WITHOUT ADVANCED BONE AGE AND EARLY ONSET OSTEOARTHRITIS) | Cristina Aguilar Riera | ![]() |
![]() |
|||
P1-073 | MINIPUBERTY IN BORN SMALL FOR GESTATIONAL AGE INFANTS: A CASE CONTROL PROSPECTIVE PILOT STUDY | Giorgia Pepe | ![]() |
![]() |
|||
P2-073 | PTEN downregulation in mouse osteoprogenitor cells impacts on bone stability and turnover | Judith Lorenz | ![]() |
![]() |
|||
P1-074 | Pancreatic glucagon-like-peptide-1 receptor expression in congenital hyperinsulinism | Diliara Gubaeva | ![]() |
![]() |
|||
P2-074 | Primary hyperparathyroidism due to a deletion of the CDC73 gene. | Liliana Mejia de Beldjenna | ![]() |
![]() |
|||
P2-075 | AFEBRILE SEIZURE IN A TODDLER GIRL WITH ALOPECIA: A CASE REPORT | Julia Galhardo | ![]() |
![]() |
|||
P1-075 | Congenital hyperinsulinism diagnosed after 12 months can have a monogenic aetiology | Jasmin Hopkins | ![]() |
![]() |
|||
P1-076 | Hyperinsulinemic Hypoglycemia in a child with Peroxisomal Biogenesis Disorder due to a Novel PEX1 mutation | NIKHIL LOHIYA | ![]() |
![]() |
|||
P2-076 | A rare cause of hypophosphatemic rickets; Non-lethal Raine syndrome | Glay Karagzel | ![]() |
![]() |
|||
P2-077 | Effect of tamoxifen on linear growth of precocious female SD rats | Huamei Ma | ![]() |
![]() |
|||
P1-077 | Real-Time Continuous Glucose Monitoring in the Management of Neonates with Persistent Hypoglycemia | Myat Win | ![]() |
![]() |
|||
P2-078 | Deleting STX16 exon 4 to understand the genetic mechanisms underlying pseudohypoparathyroidism-1B and GNAS imprinting | Cagri Aksu | ![]() |
![]() |
|||
P1-078 | Hyperinsulinemic hypoglycemia due to biallelic mutations in the DNAJC3 gene | Busra Gurpinar Tosun | ![]() |
![]() |
|||
P1-079 | Concurrent hyperinsulinism and hypopituitarism in a 22 month old child due to a novel FOXA2 mutation | Fatih Kilci | ![]() |
![]() |
|||
P2-079 | Clinical, molecular characterization and long-term follow-up of a patient with neonatal severe hyperparathyroidism | Ana Isabel Araújo Carvalho | ![]() |
![]() |
|||
P1-080 | Sphingosine 1- phosphate lyase insufficiency syndrome (SPLIS) as a cause of primary adrenal insufficiency and primary hypogonadism | Ruth Kwong | ![]() |
![]() |
|||
P2-080 | Effect of Soy and Whey on growth pattern in young male Sprague-Dawley rats | Meytal Bar Maisels | ![]() |
![]() |
|||
P2-081 | Early-onset osteoporosis due to LRP5 | pilar acuńa | ![]() |
![]() |
|||
P1-081 | Sporadic pituitary adenomas in young patients: clinical and molecular description | Idoia Martinez de LaPiscina | ![]() |
![]() |
|||
P1-082 | Cardiac remodeling in patients with childhood-onset craniopharyngioma Results of HIT-Endo and KRANIOPHARYNGEOM 2000/2007 | Panjarat Sowithayasakul | ![]() |
![]() |
|||
P2-082 | Vitamin D - What is the Optimal Level in the Pediatric Population | David Gillis | ![]() |
![]() |
|||
P1-083 | Pregnancies after childhood craniopharyngioma Results of KRANIOPHARYNGEOM 2000/2007 | Hermann L. Mller | ![]() |
![]() |
|||
P1-084 | Pituitary Duplication A rare and heterogenous spectrum | Nicole Goff | ![]() |
![]() |
|||
P2-084 | A rare cause of childhood hypercalcemia: Parathyroid adenoma | Havva Nur Peltek Kendirci | ![]() |
![]() |
|||
P2-085 | ONE GENE, TWO DISEASES:OSTEOGENESIS IMPERFECTA, OR BRUCK SYNDROME? | hasan ar&305; | ![]() |
![]() |
|||
P1-085 | Auxological and endocrine aspects in pediatric patients with Narcolepsy Type 1. Results of long-term follow up in a Pediatric Endocrinology Center | Valentina Assirelli | ![]() |
![]() |
|||
P1-086 | Adding a protease inhibitor to sampling tubes increases the acylated ghrelin and decreases the desacylated ghrelin levels in girls. | Maria Rodanaki | ![]() |
![]() |
|||
P2-086 | Spontaneous Reshaping of Vertebral Fractures in an Adolescent with Osteogenesis Imperfecta | Rodrigo Montero Lopez | ![]() |
![]() |
|||
P1-087 | GHSR protects the emergence of limited sex differences in anxiety-related behaviors in adult mice after long term THC administration during peri-adolescence | Maria Consolata Miletta | ![]() |
![]() |
|||
P2-087 | A rare presentation of Dysplasia Epiphysealis Hemimelica combined with Familial Hypocalciuric Hypercalcemia Is this association possible? | Arthur H.T. Toledo | ![]() |
![]() |
|||
P1-088 | Pituitary microadenoma in childhood is follow-up with diagnostic imaging necessary? | Camilla Borghammar | ![]() |
![]() |
|||
P2-088 | Two sibling cases with heterozygous calcium sensing receptor (CaSR) gene mutation | Erdal Kurnaz | ![]() |
![]() |
|||
P2-089 | Clinical Profile of Parathyroid Adenoma in Children and Adolescents: A single-center experience | Sirmen Kizilcan Cetin | ![]() |
![]() |
|||
P1-089 | The Pituitary Tumour Module: Developing a Condition Specific Module within the European Registries for Rare Endocrine Conditions (EuRRECa) | Ana Luisa Priego Zurita | ![]() |
![]() |
|||
P2-090 | Changing reality: rebirth of old diseases in new circumstances. Severe vitamin D deficiency presenting as hypocalcemic seizures in a healthy adolescent after prolonged COVID-19 lock-down. | Larisa Naugolny | ![]() |
![]() |
|||
P1-090 | Craniopharyngiomas presenting as incidentalomas: results of KRANIOPHARYNGEOM 2007 | Svenja Boekhoff | ![]() |
![]() |
|||
P2-091 | Two-year experience of burosumab therapy in pediatric XLH patients in Saudi Arabia | Fahad AlJuraibah | ![]() |
![]() |
|||
P1-091 | The effect of preoperative calcitriol prophylaxis on post-thyroidectomy hypocalcaemia in children | Nitash Zwaveling-Soonawala | ![]() |
![]() |
|||
P1-092 | Emotional Intelligence scores in children and adolescents with subclinical hypothyroidism - correlation with serum serotonin and thyroid stimulating hormone (TSH) concentrations. | Eirini Kostopoulou | ![]() |
![]() |
|||
P2-092 | Pseudohypoparathyroidism with hypokalemia and hypomagnesemia: association or separate entity? | Arliena Amin | ![]() |
![]() |
|||
P1-093 | LYMPHOCYTE POPULATION IN CHILDREN AND ADOLESCENTS AFFECTED BY GRAVES DISEASE. POTENTIAL PREDICTIVE TOOL OF DISEASE SEVERITY | Gerdi Tuli | ![]() |
![]() |
|||
P2-093 | Characterization of Patients with Achondroplasia in a pediatric Clinic of Cali, Colombia.P2-93 | Liliana Mejia de Beldjenna | ![]() |
![]() |
|||
P1-094 | Evaluation of children with intrathyroidal ectopic thymus | Emine Aya Cimbek | ![]() |
![]() |
|||
P2-094 | A Rare Cause of Familial Hypomagnesemia: A Case with Trpm6 Mutation | Merve Sakar | ![]() |
![]() |
|||
P1-095 | Prevalence and Characteristics of thyroid nodules in a pediatric population with congenital hypothyroidism | anne sophie lambert | ![]() |
![]() |
|||
P2-095 | Effect of cholecalciferol treatment on serum FGF-23, vitamin D-binding globulin and a-klotho levels in children with vitamin D deficiency | Zerrin Orbak | ![]() |
![]() |
|||
P1-096 | Thyroid storm and transient bulbar myopathy in a 22-month-old girl with Graves Disease | Jessica Sandy | ![]() |
![]() |
|||
P2-096 | HDR Syndrome (Barakat Syndrome): Case Report | Omneya Magdy Omar | ![]() |
![]() |
|||
P2-097 | Hungry Bone Syndrome associated to Rickets | Catalina Jiménez | ![]() |
![]() |
|||
P1-097 | The association between serum Thyrotropin within the reference range and cardiometabolic risk in obese children | Angelo Tropeano | ![]() |
![]() |
|||
P1-098 | Hypothyroid Screening in Children with Down Syndrome - A Service Evaluation | Rachael Harley | ![]() |
![]() |
|||
P2-098 | BUR-CL207: An Open-label, Multicenter, Non-randomized Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Burosumab in Pediatric Patients from Birth to Less than 1 Year of Age with XLH. | Lucy Henderson | ![]() |
![]() |
|||
P1-099 | Early adiposity rebound in children with congenital hypothyroidism diagnosed by newborn screening | Tommaso Aversa | ![]() |
![]() |
|||
P2-099 | Characterization and Risk Factors of Hyperglycaemia During Treatment Of Childhood Hematologic Malignancies | Sophie Welsch | ![]() |
![]() |
|||
P1-100 | Serum fibroblast growth factor 21 (FGF-21) levels of children and adolescents with Hashimotos thyroiditis, before and after L-thyroxin medication | Eleni P Kotanidou | ![]() |
![]() |
|||
P2-100 | The knowledge and Confidence in Management of Diabetic Ketoacidosis (DKA) among Iraqi Paediatric Residents: a Cross Sectional Study | Hussain Alsaffar | ![]() |
![]() |
|||
P1-101 | The management of adrenal cell carcinoma in a single tertiary centre: 25 year experience | Nicole Goff | ![]() |
![]() |
|||
P2-101 | Disturbances of glucose homeostasis in polytransfused beta-thalassemia patients | Noumi Mustapha | ![]() |
![]() |
|||
P2-102 | Unmet need in technology for diabetes management in the Middle East, Africa and South East Asia | Hussain Alsaffar | ![]() |
![]() |
|||
P1-102 | Correlation of 11-oxygenated C19 androgens with the clinical and biochemical characteristics in premature adrenarche | Zehra Yavas Abali | ![]() |
![]() |
|||
P2-103 | Diabetes in a child with infantile-onset multisystem neurologic, endocrine and pancreatic disease (IMNEPD) | Marianne Becker | ![]() |
![]() |
|||
P1-103 | Leukocyte telomere length in children with Congenital Adrenal Hyperplasia | Ozair Abawi | ![]() |
![]() |
|||
P1-104 | Cortison-loop is an educational tool, which helps ensure the quality of care for children with adrenal insufficiency. | Camilla Ernstsson | ![]() |
![]() |
|||
P2-104 | The clinical characteristics of hybrid diabetes (HD) in children and their response to treatment. | Noor Hamed | ![]() |
![]() |
|||
P2-105 | Recurrent episodes of hypoglycemia in an infant with type 1 spinal muscular atrophy after gene therapy: Beta oxidation defect exaggerated by hepatic dysfunction. | Nada Alaaraj | ![]() |
![]() |
|||
P1-105 | The genetic etiology of ACTH-dependent aldosterone hypersecretion in hypertensive patients without Primary Aldosteronism | Niki Mourtzi | ![]() |
![]() |
|||
P1-106 | Plasma Proteomics in Healthy Subjects with Differences in Tissue Glucocorticoid Sensitivity Identifies a Novel Proteomic Signature | Nicolas Nicolaides | ![]() |
![]() |
|||
P2-106 | Knowledge of the Final Year Medical Students Compared to Interns about the Diagnosis and management of Diabetes Mellitus | Hussain Alsaffar | ![]() |
![]() |
|||
P2-107 | A paradoxical conundrum: diabetic ketoacidosis resulting in treatment-resistant hypokalemic alkalosis | Hande Rakicioglu | ![]() |
![]() |
|||
P1-107 | Cortoic Acids: Renaissance of a Forgotten Class of Steroids | Marcel Schauermann | ![]() |
![]() |
|||
P2-108 | Impact of the COVID19 pandemic on Paediatric Diabetes Services in Arab Countries | Hussain Alsaffar | ![]() |
![]() |
|||
P1-108 | Circadian rhythm of cortisol in saliva in obese children with clinical signs of hypercortisolism | María Gabriela Ballerini | ![]() |
![]() |
|||
P1-109 | PLASMA STEROID PANEL WITH LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY (LC/MS-MS) METHOD: UTILIZATION IN DIFFERANTIAL DIAGNOSIS OF HYPERANDROGENISM | Aysun Ata | ![]() |
![]() |
|||
P2-109 | Clinical Case of Cystic Fibrosis-like and APECED-like Syndrome due to Gain-of-Function Variant in STAT1 | Vasilev Teodor | ![]() |
![]() |
|||
P2-110 | A quality improvement project of a Young Adult Diabetes (YAD) service at a UK specialist centre. | Dhruti Hirani | ![]() |
![]() |
|||
P1-110 | Current Management Of Acute Adrenal Insufficiency Related Adverse Events In Children- Results Of An International Survey Of Specialist Centres | Salma Ali | ![]() |
![]() |
|||
P2-111 | Prevalence of skin reactions among pediatrics patients with Type 1 Diabetes users of glucose sensors. | Beatriz Corredor Andrés | ![]() |
![]() |
|||
P1-111 | Insulin resistance following childhood craniopharyngioma may influence neural response to food cues in food reward-related brain regions: a preliminary investigation. | Elanor Hinton | ![]() |
![]() |
|||
P1-112 | Evaluation of the BigO behavioral indicators in overweight and obese children and adolescents | Athanasia Tragomalou | ![]() |
![]() |
|||
P2-112 | A single-centre evaluation of remote video consultation for children and young people with diabetes | Edward Andrews | ![]() |
![]() |
|||
P1-113 | Are you considering Idiopathic Intracranial Hypertension when evaluating a patient with obesity? | Louise Apperley | ![]() |
![]() |
|||
P2-113 | Health Outcome Indicators in Children with Diabetes Mellitus during the SARS-CoV-2 Pandemic | Nikita Gireesh Bhat | ![]() |
![]() |
|||
P2-114 | EVALUATION OF SERUM MYOSTATIN LEVELS IN PATIENTS WITH INSULIN DEPENDENT DIABETES MELLITUS | Beray Selver Eklio&287;lu | ![]() |
![]() |
|||
P1-114 | EuRRECa Registry Genetic Obesity Survey Results | Guftar Shaikh | ![]() |
![]() |
|||
P1-115 | Circulating C1q Complement/TNF-Related Protein (CTRP)-13 Levels in Obese Children and Its Relationship with Metabolic Disorders | Ibrahim Mert Erbas | ![]() |
![]() |
|||
P2-115 | HbA1c and Glucose Management Indicator relationship: can HbA1c determination be avoided? | Constanza Navarro Moreno | ![]() |
![]() |
|||
P1-116 | An Evidence-based Framework to Evaluate Melanocortin-4 Receptor (MC4R) Pathway Relevance for Obesity-associated Genes | Bhavik Shah | ![]() |
![]() |
|||
P2-116 | Sex differences over two decades for glycaemic control, pump use and insulin dose in patients aged 10-20 years with type 1 diabetes | Claudia Boettcher | ![]() |
![]() |
|||
P2-117 | Cardiovascular risk factors in adolescents with type 1 diabetes: Prevalence and gender differences | Dogus Vuralli Karaoglan | ![]() |
![]() |
|||
P1-117 | Serum Fibroblast Growth Factor 23 and Klotho concentrations in children and adolescents with obesity. | Sofia-Iliada Karampatsou | ![]() |
![]() |
|||
P2-118 | Bilateral severe proliferative retinopathy, macular oedema, and lack of macrocytosis in an adolescent male with thiamine-responsive megaloblastic anaemia | Manju Chandwani | ![]() |
![]() |
|||
P1-118 | RARE HETEROZYGOUS VARIANTS IN GENES OF THE LEPTIN-MELANOCORTIN SATIETY PATHWAY CONTRIBUTE TO CHILDHOOD OBESITY | Gabriel Á. Martos-Moreno | ![]() |
![]() |
|||
P1-119 | Diagnostic precision of the Tri-Ponderal Mass Index (kg/m3) to identify the metabolically unhealthy obesity phenotype in obese children and adolescents. | Larry Arciniegas | ![]() |
![]() |
|||
P2-119 | First Survey About Pediatric Diabetes Services in Iraq | Hussain Alsaffar | ![]() |
![]() |
|||
P2-120 | Effect of metabolic control on the presence of Nonalcoholic Fatty Liver Disease (NAFLD) in adolescents with type 2 Diabetes. | Jose Antonio Orozco Morales | ![]() |
![]() |
|||
P1-120 | Monogenic obesity in children: focusing on SH2B1 deletion | Eleni Giannopoulou | ![]() |
![]() |
|||
P1-121 | Higher rates of non-skeletal complications in achondroplasia compared to the general population: a UK matched cohort study using the CPRD database | Melita Irving Pimenta | ![]() |
![]() |
|||
P2-121 | The effect of glycemic variability on DNA damage in pediatric patients with type 1 Diabetes Mellitus | Ayca Altincik | ![]() |
![]() |
|||
P1-122 | Short stature in Protein Arginine Methyltransferase 7 (PRMT7) mutations: first evidences of growth response to rGH treatment | Giulia Rodari | ![]() |
![]() |
|||
P2-122 | Parental insulin resistance is associated with unhealthy lifestyle behaviours independently of body mass index in children: The Feel4Diabetes study | Esther Gonzalez-Gil | ![]() |
![]() |
|||
P1-123 | Growth and nutrition improvement with recombinant growth hormone in prepubertal patients with Silver-Russell syndrome | Elose Giabicani | ![]() |
![]() |
|||
P2-123 | Use of the whole country insulin consumption data in Israel showed a reduced prevalence of type 1 diabetes in children aged 5 years during universal Rotavirus vaccination | Zvi Laron | ![]() |
![]() |
|||
P2-124 | PSYCHOLOGICAL CHANGES IN YOUTH WITH DIABETES: COMPARISON BETWEEN PREADOLESCENTS AND ADOLESCENTS | Roberta Longaretti | ![]() |
![]() |
|||
P1-124 | Management of endocrine aspects of Noonan syndrome across Europe: A subanalysis of a European clinical practice survey | Thomas Edouard | ![]() |
![]() |
|||
P2-125 | Focal Congenital Hyperinsulinism in Infancy is Directly Linked to Increased Numbers of Islet Pancreatic Polypeptide Cells in Islets. | Chris Worth | ![]() |
![]() |
|||
P1-125 | PROPEL2: a phase 2, open-label, dose-escalation and dose-expansion study of infigratinib in children with achondroplasia (ACH) | Lee Miller | ![]() |
![]() |
|||
P1-126 | Identification and tissue-specific characterization of novel SHOX-regulated genes in zebrafish highlights SOX family members among other genes | Gudrun A. Rappold | ![]() |
![]() |
|||
P2-126 | Oral administration of CRN04777, a nonpeptide ive SST5 receptor agonist, suppresses insulin secretion and rescues hypoglycemia in neonatal rat models of congenital hyperinsulinism | Melissa Fowler | ![]() |
![]() |
|||
P1-127 | Evaluation of early puberty in boys and girls with Silver-Russell Syndrome: Discordance between testicular growth and pituitary-gonadal hormones in male cases | Melek Yildiz | ![]() |
![]() |
|||
P2-127 | Thiamine-responsive megaloblastic anemia: a rare presentation of an uncommon disease | Yasmine Abdelmeguid | ![]() |
![]() |
|||
P1-128 | Evaluation of Persistent Short Stature in Children Born Small for Gestational Age without Catch-up Growth | Ayse Pinar ztrk | ![]() |
![]() |
|||
P2-128 | Daily Meal Size Variation Does Not Affect Glycemic Control In T1D Adolescent Patients Equipped With The Closed Loop DBLG1 System | Paul Gimenez | ![]() |
![]() |
|||
P2-129 | Evaluation of continuous glucose monitoring for the diagnosis of Cystic Fibrosis Related Diabetes (CFRD): A prospective and longitudinal study | Pamela Yesquen | ![]() |
![]() |
|||
P1-129 | Computer-aided facial analysis as a tool to identify patients with Silver-Russell syndrome and Prader-Willi syndrome | Silvia Ciancia | ![]() |
![]() |
|||
P2-130 | BLOOD LIPID CONCENTRATIONS OF NEWBORNS AND THEIR MOTHERS WITH GESTATIONAL DIABETES | Olga Gumeniuk | ![]() |
![]() |
|||
P1-130 | Study design and baseline characteristics of children enrolled in PROPEL: A prospective clinical assessment study in children with achondroplasia (ACH) | Lee Miller | ![]() |
![]() |
|||
P2-131 | Comparison between hybrid diabetes (HD) and type 2 diabetes (T2DM) in children; Patients characteristics at diagnosis: a retrospective observational study. | Noor Hamed | ![]() |
![]() |
|||
P1-131 | The impact of lockdown regulations caused by the COVID-19 pandemic on adherence to recombinant human growth hormone therapy: Evidence from real-world data | Paula Van Dommelen | ![]() |
![]() |
|||
P1-132 | Use of growth hormone therapy in short patients born small for gestational age: data from real-life French clinical practice | Régis Coutant | ![]() |
![]() |
|||
P1-133 | Efficacy and safety profile of recombinant insulin like growth factor 1 (rh IGF1) therapy: A long term follow up study at a single tertiary centre. | Sommayya Aftab | ![]() |
![]() |
|||
P1-134 | Starting recombinant human growth hormone treatment at an early age improves adherence and catch-up growth in patients with growth disorders, and highlights the importance of the new guideline on referral of short children to paediatric care | Paula Van Dommelen | ![]() |
![]() |
|||
P2-134 | DOES SARS-COV-2 OUTBREAK INCREASES DIABETIC KETOACIDOSIS IN NEW ONSET T1DM | Arzu Jalilova | ![]() |
![]() |
|||
P1-135 | Long-term safety of growth hormone in adults and adolescents with growth hormone deficiency: An overview of the full-cohort in KIMS | Gudmundur Johannsson | ![]() |
![]() |
|||
P2-136 | Evaluation of the Effect of Carbohydrate Count on Nutritional Habits and Metabolic Control in Adolescents with Type 1 Diabetes | Havva Nur Peltek Kendirci | ![]() |
![]() |
|||
P1-136 | Comparison of actual GH dose with labeled dose in children with short stature based on the LG Growth Study | Hae Sang Lee | ![]() |
![]() |
|||
P1-137 | Persistently increased IGF-I levels and excellent auxological response despite low doses of recombinant growth hormone in a GH-deficient patient with a heterozygous variant of the growth hormone receptor (GHR) gene | Maria Laura Nicolosi | ![]() |
![]() |
|||
P2-137 | Nutritional evaluation of children with type 1 diabetes on admission to the Endocrinology-Diabetology and Nutrition Department | Nisrine Bouichrat | ![]() |
![]() |
|||
P1-138 | Safety and effectiveness of pediatric growth hormone therapy: Results from the full cohort in KIGS | Mohamad Maghnie | ![]() |
![]() |
|||
P2-138 | Correlation between antiinsulin autoantibodies and clinical presentation in T1DM | Elena Sukarova-Angelovska | ![]() |
![]() |
|||
P1-139 | The effect of growth hormone therapy on linear growth and weight gain in children with growth hormone deficiency vs idiopathic short stature (ISS) ; a controlled study | Sohair Elsiddig | ![]() |
![]() |
|||
P2-139 | Different schemes of insulin therapy (CSII and MDII) in children with DM1 in a Dnipro city. | Viktoria Yenhovatova | ![]() |
![]() |
|||
P1-140 | Linear growth response top Growth hormone therapy in underweight versus normal-weight children with idiopathic short stature (ISS). | soahir Elsiddig | ![]() |
![]() |
|||
P2-140 | HbA1c of T1DM Patients before and after Transition - Single Center Experience | Rand Al Harthy | ![]() |
![]() |
|||
P2-141 | Glycated Hemoglobin Variability and Microvascular Complications in Patients with Type 1 Diabetes Mellitus | Eren Er | ![]() |
![]() |
|||
P1-142 | Investigation of primary adrenal insufficiency (PAI) in children with 46,XY differences in sex development (DSD) | Elim Man | ![]() |
![]() |
|||
P2-142 | Affective response of newly diagnosed Type1 diabetes parents: An experience of a developing country. | Aqeela Ayub | ![]() |
![]() |
|||
P2-143 | SHORT-TERM GLYCAEMIC CHANGES FROM CONTINUOUS GLUCOSE MONITORING AMONG CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES MELLITUS DURING FASTING IN RAMADAN MONTH | Sze Teik Teoh | ![]() |
![]() |
|||
P1-143 | Current clinical practice of prenatal dexamethasone treatment in at risk pregnancies for classic 21-hydroxylase deficiency in Europe | Hanna F. Nowotny | ![]() |
![]() |
|||
P2-144 | Is Type 1 Diabetes Mellitus Predictable? Investigation of Predictive Markers n Siblings of Probands with Newly Diagnosed Type 1 Diabetes Mellitus | Serpil Albayrak | ![]() |
![]() |
|||
P1-144 | Ovarian AMH production is transiently affected in pubertal and prepubertal girls with acute lymphoblastic leukaemia and non-Hodgkin lymphoma receiving chemotherapy: a prospective, longitudinal study. | Jimena C. Lopez Dacal | ![]() |
![]() |
|||
P1-145 | Serum anti-Mllerian hormone as a marker of ovarian reserve among childhood cancer survivors | Silvia Molinari | ![]() |
![]() |
|||
P2-145 | Dealing with hypoglycaemia during acute DKA management by paediatric residents from Bahrain, Iraq and Saudi Arabia | Hussain Alsaffar | ![]() |
![]() |
|||
P2-146 | A Rare Clinical Case Of A Combination Of Monogenic And Autoimmune Diabetes Mellitus. | Elizaveta Romanenkova | ![]() |
![]() |
|||
P1-146 | Reaching a definitive diagnosis of hypogonadotropic hypogonadism experience of a multidisciplinary diagnostic service | Supitcha Patjamontri | ![]() |
![]() |
|||
P2-147 | Thrombocytopaenia induced by diazoxide treatment in a toddler with Hyperinsulinism-Hyperammonemia syndrome: a rare side-effect | Zacharoula Karabouta | ![]() |
![]() |
|||
P1-147 | A pre-analytical challenge to determine estradiol in children: A monovette systematically causing increased estradiol-concentrations in LC-MS/MS analysis | Tabea Lamprecht | ![]() |
![]() |
|||
P1-148 | Central precocious puberty and sleep patterns in COVID-19 outbreak | Anna Grandone | ![]() |
![]() |
|||
P2-148 | Nephrotic Syndrome and Type 1 Diabetes: a Therapeutic Approach | Beatriz Vala | ![]() |
![]() |
|||
P2-149 | Assessment of the percentage of T lymphocytes and B lymphocytes with the expression of ed activation markers in patients with type 1 diabetes mellitus depending on the presence of antibodies against EBV antigens. | Izabela Rysz | ![]() |
![]() |
|||
P1-149 | QUERY by TELARQUIA: Has there been an increase due to the SARS-COV19 pandemic? | Ignacio Diez-Lopez | ![]() |
![]() |
|||
P1-150 | Androgen insensitivity without an androgen receptor mutation: results from a large cohort study | Nadine Hornig | ![]() |
![]() |
|||
P2-150 | PIMS-TS Paediatric Inflammatory Multisystem Syndrome Temporally associated with SARS-CoV-2 (Covid-19) in a child with new onset type 2 diabetes | Sophia Sakka | ![]() |
![]() |
|||
P1-151 | Duration of Fasting Studies Required to Demonstrate a Cure for Patients with Focal Congenital Hyperinsulinism. | Paul S Thornton | ![]() |
![]() |
|||
P2-151 | The impact of COVID-19 lockdown on glycaemic control and BMI in children with type 1 diabetes mellitus (T1DM) | Saji Alexander | ![]() |
![]() |
|||
P1-152 | IMPACT OF GESTATIONAL WEIGHT GAIN ON METHYLATION OF IMPRINTED GENES IN UMBILICAL CORD AND ITS RELATIONSHIP WITH POSTNATAL GROWTH AND METABOLISM | Berta Mas-Parés | ![]() |
![]() |
|||
P2-152 | Timing of Consulting Paediatric Endocrinologist or Diabetologist During the Management of Acute DKA; Response of Bahraini, Iraqi, and Saudi Paediatric Residents | Hussain Alsaffar | ![]() |
![]() |
|||
P1-153 | DIFFERENT FACES OF MINIPUBERTY IN PRETERM TWIN GIRLS | Giorgia Pepe | ![]() |
![]() |
|||
P2-154 | Neonatal Diabetes Secondary to Isolated Pancreatic Agenesis | Sarah Bakhamis | ![]() |
![]() |
|||
P1-154 | The Evaluation of Accuracy and Effectiveness of Newborn Screening for Congenital Adrenal Hyperplasia in Lithuania | Ruta Navardauskaite | ![]() |
![]() |
|||
P2-155 | DYSLIPIDEMIA IN CHILDREN WITH TYPE 1 DIABETES MELLITUS | Olga Gumeniuk | ![]() |
![]() |
|||
P1-155 | Pediatric Inflammatory Multisystemic Syndrome in Brazil: sociodemographic characteristics and risk factors to death | Renata Machado Pinto | ![]() |
![]() |
|||
P1-156 | Molecular and phenotypic profile of Alstrom syndrome in Chinese patients:results from a Chinese cohort | Qianwen Zhang | ![]() |
![]() |
|||
P2-156 | THE RELATIONSHIP BETWEEN METABOLIC PARAMETERS,ATHEROGENIC INDEX AND VITAMIN D LEVELS IN CHILDREN WITH INSULIN-DEPENDENT DIABETES MELLITUS | Beray SELVER EKL&304;OGLU | ![]() |
![]() |
|||
P2-157 | A case of severe hypertriglyceridaemia complicating new-onset type 1 diabetes mellitus | Khadidja Belkhatir | ![]() |
![]() |
|||
P1-157 | Endocrine Monitoring and Outcome After Therapy In Childhood Survivors of Central Nervous System Tumours | Misha Gilani | ![]() |
![]() |
|||
P1-158 | Low adrenal androgen levels in patients with and without primary adrenal insufficiency in APECED (APS1) | Joonatan Borchers | ![]() |
![]() |
|||
P2-158 | A novel variant HNF1A gene (HNF1A-MODY) in a patient presenting with hyperglycaemia and glycosuria | Zacharoula Karabouta | ![]() |
![]() |
|||
P1-159 | CLINICAL FEATURES AND BODY MINERAL DENSITY IN ITALIAN PATIENTS WITH RAPID ONSET OBESITY WITH HYPOVENTILATION, HYPOTALAMIC DYSFUNCTION, AUTONOMIC DISREGULATION AND NEURAL TUMOR (ROHHADNET): A SINGLE CENTER OBSERVATIONAL STUDY | Alessia Angelelli | ![]() |
![]() |
|||
P2-159 | Glucose 6 phosphate dehydrogenase deficiency diagnosed with hemolytic anemia triggered by diabetes mellitus type 1 | Burce Orman | ![]() |
![]() |
|||
P1-160 | Congenital Central Hypothyroidism (CCH) due to a new variant in IGSF1 gene: clinical case of 2 siblings | Marco Abbate | ![]() |
![]() |
|||
P2-160 | HbA1C stability is posting samples reliable? | Nicola Davey | ![]() |
![]() |
|||
P2-161 | Not every obese child has type 2 Diabetes Mellitus | Diamanto Koutaki | ![]() |
![]() |
|||
P1-161 | Continued Safety and Efficacy of Weekly Lonapegsomatropin (TransCon hGH) for up to Two Years in Children with Growth Hormone Deficiency (GHD) | Elena Aghajanova | ![]() |
![]() |
|||
P1-162 | Evaluation of growth patterns from the Edinburgh and Gothenburg cohorts by the QEPS model | Anton Holmgren | ![]() |
![]() |
|||
P2-162 | Does insulin pump therapy improve glycaemic control in type 1 diabetes children: one year follow up | Najoua MESSAOUDI | ![]() |
![]() |
|||
P2-163 | Mauriac syndrome: a complication that still exists in children with type 1 diabetes. Report of a case. | Catalina Jiménez | ![]() |
![]() |
|||
P1-163 | The aetiology of extreme tall stature in a screened Finnish paediatric population | Juho Krkinen | ![]() |
![]() |
|||
P2-164 | The Impact of COVID 19 Pandemic on Type 1 Diabetes Mellitus: An experience of a Tertiary Care Hospital in a resource limited country | Aqeela Ayub | ![]() |
![]() |
|||
P1-164 | Long-term efficacy and safety of rhGH in children with SHOX deficiency: preliminary data of a national Italian survey (on behalf of ISPED Study Group on Growth Factors and Puberty). | Patrizia Bruzzi | ![]() |
![]() |
|||
P2-165 | Co-existence of new onset diabetic ketoacidosis with severe hypertriglyceridemia in a 9 year old girl. | Fatih Kilci | ![]() |
![]() |
|||
P1-165 | Eight years of GH treatment in children with PWS: The earlier the start, the better the outcomes? | Lionne Grootjen | ![]() |
![]() |
|||
P1-166 | The BoneXpert adult height prediction method outperforms the Bayley and Pinneau method in tall male adolescents. | Jean De Schepper | ![]() |
![]() |
|||
P2-166 | How Does Continuous Glucose Monitoring Systems Effect Metabolic Control In Type 1 Diabetes: Single Center Experience | Emrullah Arslan | ![]() |
![]() |
|||
P2-167 | Blood level of Vitamin D and metabolic control of type 1 diabetes mellitus | Maryam Razzaghy-Azar | ![]() |
![]() |
|||
P1-167 | Sex differences in growth response to GH treatment: more prepubertal and less pubertal gain in girls diagnosed with IGHD, ISS, SGA. Analysis of data from GH-SAFETY-database, including all children treated with rhGH- 1986-2009 in Sweden, in National-GH-Reg | Elena Lundberg | ![]() |
![]() |
|||
P2-168 | Newly-onset type 1 diabetes mellitus triggered by COVID-19: Original case report | Salma Benyakhlef | ![]() |
![]() |
|||
P1-168 | Mothers smoking during pregnancy influence intrauterine and postnatal growth - the GrowUp 1990 Gothenburg cohort population | Kerstin Albertsson Wikland | ![]() |
![]() |
|||
P1-169 | Safety of growth hormone and cardiovascular outcomes in patients with Noonan syndrome enrolled in NordiNet International Outcome Study (IOS) and the ANSWER Program | Michel Polak | ![]() |
![]() |
|||
P2-169 | Case of HNF1B MODY | Viktoria Yenhovatova | ![]() |
![]() |
|||
P2-170 | Diabetes Ketoacidosis Recovery in Youth with Newly Diagnosed and Established Type 1 Diabetes | Keren Smuel Zilberberg | ![]() |
![]() |
|||
P1-170 | Facilitating Telehealth In A Tertiary Paediatric Endocrine Service: A Quality Improvement Initiative To Reduce The Discrepancy Between Parent-reported And Auxologist Height Measurements | Sinead McGlacken-Byrne | ![]() |
![]() |
|||
P2-171 | Association of calprotectin with obesity in prepubertal children | Jong Seo Yoon | ![]() |
![]() |
|||
P1-171 | Diagnosing growth hormone deficiency - Can a combined arginine and clonidine stimulation test replace two separate tests? | Tal Oron | ![]() |
![]() |
|||
P1-172 | Glucagon Testing of Childhood-Onset Growth Hormone Deficiency during Transition | Davide Guglielmi | ![]() |
![]() |
|||
P2-172 | Metabolic syndrome and birth anthropometric data in Prader-Willi syndrome. | Alessandro Salvatoni | ![]() |
![]() |
|||
P2-173 | Evaluation of the BigO system during the COVID-19 outbreak in Greece | Athanasia Tragomalou | ![]() |
![]() |
|||
P1-173 | Growth hormone receptor 6O pseudoexon activation: a novel cause of severe growth hormone insensitivity | Emily Cottrell | ![]() |
![]() |
|||
P2-174 | THE RELATIONSHIP BETWEEN SLEEP TIME AND OBESITY IN CHILDHOOD | Ekin Zeynep Altun | ![]() |
![]() |
|||
P1-174 | High incidence and male predominance of transient form of isolated growth hormone (GH) deficiency in children. What is the optimal time for GH therapy withdrawal and retesting? | Joanna Smyczynska | ![]() |
![]() |
|||
P1-175 | GROWTH WITHOUT GROWTH HORMONE. A TERTIARY CARE HOSPITALS EXPERIENCE | Sandra Cuenca-Carcelén | ![]() |
![]() |
|||
P2-175 | THE RELATIONSHIP BETWEEN ACANTHOSIS NIGRICANS AND VITAMIN D IN OBESE CHILDREN AND ADOLESCENTS | Ekin Zeynep Altun | ![]() |
![]() |
|||
P1-176 | Irisin in the growth hormone deficient children: before and on rhGH therapy. | Wikiera Beata | ![]() |
![]() |
|||
P2-176 | Exploring Urinary Bile Acids as Potential Markers of Metabolism: Reference Values in Children by Targeted LC-MS/MS | Marcel Schauermann | ![]() |
![]() |
|||
P1-177 | Immunogenicity of recombinant growth hormone and relationship its growth-promoting effect in the children with short stature | Murat Karaoglan | ![]() |
![]() |
|||
P1-178 | Study on linear growth of children with idiopathic short children (ISS) with Low Insulin-like growth factor 1 (IGFI) at diagnosis: Growth hormone (GH) treatment versus no treatment. | Sohair Elsiddig | ![]() |
![]() |
|||
P2-179 | Frequency of MC4R Pathway Variants in a Large US Cohort of Pediatric and Adult Patients with Severe Obesity | Ida Moeller | ![]() |
![]() |
|||
P1-179 | Novel dominant negative GH receptor variants provide important insights into GH receptor physiology | Afiya Andrews | ![]() |
![]() |
|||
P1-180 | The miRNA network and the interplay between growth and cancer regulating pathways in prepubertal patients with idiopathic isolated growth hormone deficiency (IGHD) on growth hormone (GH) treatment | Maria Elisabeth Street | ![]() |
![]() |
|||
P2-180 | Impact of the COVID-19 pandemic and related lockdown measures on lifestyle behaviours and quality of life in children and adolescents with severe obesity | Mila Welling | ![]() |
![]() |
|||
P1-181 | Continuous versus discontinuous administration of gonadotropins in neonates with congenital hypogonadotropic hypogonadism | Tristan Avril | ![]() |
![]() |
|||
P2-181 | Longitudinal association of the anti-inflammatory serum marker GDF-15 with serum IgA and IgG in apparently healthy children | Gemma Carreras-Badosa | ![]() |
![]() |
|||
P2-182 | Describing the Natural History of Clinical, Biochemical and Radiological outcomes of Children with Familial Partial Lipodystrophy type 2 (FPLD2) attending a National Service for Severe Insulin Resistance: a Retrospective Cohort Study | Zhu Xuan Zhong | ![]() |
![]() |
|||
P1-182 | Sequence of MKRN3 and DLK1 genes in cases with familial central precocious puberty | Esin Karakilic-Ozturan | ![]() |
![]() |
|||
P2-183 | Evaluation of the BigO system in a clinical setting in Greece | Athanasia Tragomalou | ![]() |
![]() |
|||
P2-184 | ASSESSMENT OF DRD2 DOPAMINE RECEPTOR GENE rs6277 IN PEDIATRIC OBESITY: A CASE-CONTROL STUDY | Renata Machado Pinto | ![]() |
![]() |
|||
P1-184 | The pituitary gonadal axis is not responsive to GnRH administration in PCSK 1 dysfunction | Espen Eliyahu Mendelsohn | ![]() |
![]() |
|||
P1-185 | Puberty and pituitary-gonadal axis function after treatment for a childhood brain tumor | Manon Rosimont | ![]() |
![]() |
|||
P2-185 | A Comprehensive, Multidisciplinary, Personalized, Lifestyle Intervention Program is Associated with Increased Leukocyte Telomere Length in Children and Adolescents with Overweight and Obesity | George Paltoglou | ![]() |
![]() |
|||
P2-186 | Diagnostic accuracy of Tri-Ponderal mass index (kg/m3) for identifying glucose intolerance in obese children and adolescents. | Larry Arciniegas | ![]() |
![]() |
|||
P1-186 | Serum Testosterone and Estradiol Serve as Markers of Growth Response During Puberty Promoting Treatment | Heta Huttunen | ![]() |
![]() |
|||
P1-187 | The Adrenal Steroid Profile in Adolescent Depression: A Valuable Bio-Readout? | Raphael Hirtz | ![]() |
![]() |
|||
P2-187 | EFFECT OF SEMAGLUTIDE ON BODY WEIGHT IN OBESE CHILDREN WITH CRANIOPHARYNGIOMA : A PRELIMINARY REPORT | Marie Jourdren | ![]() |
![]() |
|||
P1-188 | Congenital hypogonadotropic hypogonadism in a large French cohort : New genetic findings | Abir Talbi | ![]() |
![]() |
|||
P2-188 | Development of a predictive normogram to assess the risk of liver steatosis in childhood obesity | Gabriel Á. Martos-Moreno | ![]() |
![]() |
|||
P2-189 | Prospective evaluation of liver stiffness in obese children: the role of shear wave elastography. | Domenico Corica | ![]() |
![]() |
|||
P1-189 | Dimensional changes in structures of craniofacial and brain in precocious puberty: Developmental surrogate markers of the brain as a secondary sex characteristic in puberty | Murat Karaoglan | ![]() |
![]() |
|||
P1-190 | Six novel variants in the MKRN3 gene causing central precocious puberty: characteristics of ten patients and their affected relatives | Caroline Gernay | ![]() |
![]() |
|||
P2-190 | Evaluation of the nutritional behavior of small and large for gestational age children | Anzhalika Solntsava | ![]() |
![]() |
|||
P2-191 | Resting energy expenditure and body composition in children and adolescents with severe obesity due to (suspected) medical causes: comparison between different subtypes of obesity | Ozair Abawi | ![]() |
![]() |
|||
P1-191 | The Impact of Hospital Surgical Volume on Healthcare Utilisation Outcomes after Paediatric Thyroidectomy | Alexander Chesover | ![]() |
![]() |
|||
P1-192 | Analysis of hypothyroidism NGS test in Korean patients with congenital hypothyroidism in a single center | So Yoon Jung | ![]() |
![]() |
|||
P2-192 | Exercise-induced expression of myokines in adolescents with simple obesity. | Yulia Kasyanova | ![]() |
![]() |
|||
P1-193 | Further evidence that Borealin/CDCA8 is involved in thyroid morphogenesis and aging | Aurore Carré | ![]() |
![]() |
|||
P2-193 | Early decline in sertoli cell function during puberty in overweight and obese boys : a cross-sectional study | solčne Rérat | ![]() |
![]() |
|||
P1-194 | Role of Next Generation Sequencing in the etiological diagnosis of congenital hypothyroidism with gland in situ | Valeria Di Natale | ![]() |
![]() |
|||
P2-195 | Assessment of Hyperphagia in Patients with Monogenic Obesity | Stefanie Zorn | ![]() |
![]() |
|||
P2-196 | Machine Learning Quest for Predictive Markers of Lifestyle Modification Outcomes in Pediatric Obesity Treatment | Aneta Gawlik | ![]() |
![]() |
|||
P1-196 | Clinical and Molecular Presentation of Congenital Hypothyroidism Caused by Thyroglobulin Gene Mutations | Sarah Bakhamis | ![]() |
![]() |
|||
P1-197 | MANAGEMENT OF NEWBORNS BORN TO MOTHERS WITH AUTOIMMUNE HYPOTHYROIDISM | Paolo Cavarzere | ![]() |
![]() |
|||
P2-197 | TRIPONDERAL MASS INDEX FOR THE CATEGORISATION OF CHILDHOOD OBESITY ON THE BASIS OF 58.364 OBSERVATIONS OF 7.792 PATIENT | Raquel Corripio | ![]() |
![]() |
|||
P2-198 | Successful weight loss and resolution of hepatic fibrosis in a girl with severe obesity | Louise Apperley | ![]() |
![]() |
|||
P1-198 | Novel single nucleotide variation in DUOX2 and NPTX1 genes in two Sardinian sisters with transient congenital hypothyroidism | Anastasia Ibba | ![]() |
![]() |
|||
P1-199 | New p.Ser237Asn Activating Mutation At The TSHR Receptor, Causing Familial Non- Autoimmune Hyperthyroidism | Artur Bossowski | ![]() |
![]() |
|||
P2-199 | Association of Thyroid-Stimulating Hormone and Free Thyroxine Concentrations with Cardiometabolic Risk Factors in Euthyroid Obese Children and Adolescents with Metabolic Syndrome | NANSY TRAGOMALOU | ![]() |
![]() |
|||
P1-200 | Functional studies of PAX8 gene variants in patients affected by congenital hypothyroidism with eutopic thyroid gland | Núria Camats | ![]() |
![]() |
|||
P2-200 | Impact of weight loss on gonadic function in overweight and obese boys | solčne Rérat | ![]() |
![]() |
|||
P2-201 | Weight status and body composition of children and adolescents during the COVID-19 pandemic | Avivit Brener | ![]() |
![]() |
|||
P2-202 | The challenges faced in the management of Congenital Generalized Lipodystrophy. | Yasmine Abdelmeguid | ![]() |
![]() |
|||
P2-203 | ANTHROPOMETRIC AND CLINICAL SITUATION IN TWO GROUPS OF YOUNG ADULTS BORN SMALL FOR GESTATIONAL AGE ( A GROUP WITH CATCH-UP AND ANOTHER WITHOUT CATCH-UP AND TREATED WITH GROWTH HORMONE) | Amaya Vela | ![]() |
![]() |
|||
P2-204 | Changes in objectively measured physical activity after 2-year lifestyle intervention in pediatric patients with abdominal obesity | Maria Cristina Azcona-Sanjulian | ![]() |
![]() |
|||
P2-205 | Assessment of cardiometabolic risk factor clustering in obese children and adolescents with metabolic syndrome | NANSY TRAGOMALOU | ![]() |
![]() |
|||
P2-206 | HOMA-IR in obese children with BMI =2.5SDS, but not 2.5SDS, differ significantly from normal weight children | Sofia Leka-Emiri | ![]() |
![]() |
|||
P2-207 | Restriction of physical activity is the main cause of childhood obesity during the COVID-19 pandemic reflections from a study conducted in 3 clinical centers in southern Poland | Agnieszka Zachurzok | ![]() |
![]() |
|||
P2-208 | OSAS in childhood obesity is a more frequent and earlier complication than expected | Giulio Maltoni | ![]() |
![]() |
|||
P2-209 | A novel homozygous variant of the leptin receptor (LEPR) gene causing familiar early-onset severe obesity in two siblings | Silvia Molinari | ![]() |
![]() |
|||
P2-210 | Sleep quality and metabolic syndrome in pediatric patients with abdominal obesity | María Cristina Azcona-Sanjulian | ![]() |
![]() |
|||
P2-211 | The lockdown effects on a pediatric obese population in the COVID-19 era | Federica DAmico | ![]() |
![]() |
|||
P2-212 | The Relationship between Acanthosis Nigricans and Vitamin D Levels in Obese Children | Beray Selver Eklioglu | ![]() |
![]() |
|||
P2-213 | Influence of birth weight on cardiovascular risk factors in obese children and adolescents | Chiara Guzzetti | ![]() |
![]() |
|||
P2-214 | A study on the Complications associated with Severe Obesity in Children and Young People | Louise Apperley | ![]() |
![]() |
|||
P2-215 | The Effectiveness of Indigenous Knowledge-Based Lifestyle Interventions in Preventing Obesity and Type 2 Diabetes Mellitus in Indigenous Children in Canada: A Systematic Review | Maya Kshatriya | ![]() |
![]() |
|||
P2-216 | The effects of dextroamphetamine treatment in children with hypothalamic obesity | Mila Welling | ![]() |
![]() |
|||
P2-218 | Impact of overweight and obesity in pediatrics. Metabolic syndrome and its components | Ignacio Diez-Lopez | ![]() |
![]() |
|||
P2-219 | What do lipids tell us about the pandemic? | Myrna Campagnoli | ![]() |
![]() |
|||
P2-221 | Sleep Properly, Reduce Intake, aNd Get Stepping (SPRINGS): a multidisciplinary approach to managing paediatric morbid obesity with severe obstructive sleep apnoea | Katherine Hawton | ![]() |
![]() |
|||
P2-222 | Design of a Phase 2, Double-Blind, Placebo-Controlled Trial of Setmelanotide in Patients With Genetic Variants in the Melanocortin-4 Receptor Pathway | Cecilia Scimia | ![]() |
![]() |
|||
P2-223 | Absence of dyslipidemia in obese children with BMI =2.5SDS and similar lipidemic profile to those with BMI 2.5SDS or normal weight | Sofia Leka-Emiri | ![]() |
![]() |
|||
P2-224 | Inflammation associated to body composition in European prepubertal children: Results from the IDEFICS study | Pilar Argente | ![]() |
![]() |
|||
P2-226 | THYROID FUNCTION IN YOUTH WITH METABOLIC SYNDROME | Olena Tolstikova | ![]() |
![]() |
|||
P2-227 | Global survey study of awareness, care and treatment of adolescents living with obesity, their caregivers and healthcare professionals: ACTION Teens | Jason C.G. Halford | ![]() |
![]() |
|||
P2-228 | Lifestyle habits, consumption of non-nutritive sweeteners and obesity in students and young adults population in Latvia. | Zane Roze | ![]() |
![]() |
|||
P2-229 | Influence of the basal metabolic profile on the evolution of the pediatric patient with obesity | Ignacio Diez-Lopez | ![]() |
![]() |
|||
P2-230 | The utility of continuous glucose monitoring systems in the management of children with persistent hypoglycaemia | Sathyakala Vijayanand | ![]() |
![]() |
|||
P2-231 | Hyperinsulinaemic hypoglycaemia as a MEHMO syndrome component: a case report | Diliara Gubaeva | ![]() |
![]() |
|||
P2-232 | METHYLATION OF UMBILICAL CORD GENES ASSOCIATES WITH GESTATIONAL WEIGHT GAIN AND OFFSPRINGS CARDIO-METABOLIC PROFILE | Berta Mas-Parés | ![]() |
![]() |
|||
P2-233 | DIAZOXIDE RESPONSIVE CONGENITAL HYPERINSULINISM | Nikhil Lohiya | ![]() |
![]() |
|||
P2-234 | Continuous Glucose Monitoring (CGM) Reveals Undertreated Hypoglycemia in Patients with Congenital Hyperinsulinism | Davelyn Hood | ![]() |
![]() |
|||
P2-235 | A Selective Nonpeptide Somatostatin Receptor 5 (SST5) Agonist Effectively Decreases Insulin Secretion in a KATPHI Mouse Model and in Human HI Islets | Diva De Leon | ![]() |
![]() |
|||
P2-236 | PLACENTAL FRAT-1 METHYLATION IN WOMEN WITH GESTATIONAL OBESITY IS ASSOCIATED WITH THE BODY COMPOSITION IN THE OFFSPRING AT 6 YEARS OF AGE | Ariadna Gómez-Vilarrubla | ![]() |
![]() |
|||
P2-237 | PLACENTA N-6/N-3 PUFA RATIO IS ASSOCIATED WITH VISCERAL ADIPOSITY AND CARDIOVASCULAR RISK IN THE OFFSPRING AT 6 YEARS OF AGE | Ariadna Gómez-Vilarrubla | ![]() |
![]() |
|||
P2-238 | Analysis of Placental Steroidogenesis as a Cause of Recurrent Miscarriage | Jenifer Suntharalingham | ![]() |
![]() |
|||
P2-239 | Antenatal Markers Related to Fetal Growth Restriction Can Predict Childhood Systolic Blood Pressure | Reena Perchard | ![]() |
![]() |
|||
P2-240 | Hypomethylation of the Prader-Willi imprinting control region associates with postnatal growth and visceral adiposity in healthy children | Gemma Carreras-Badosa | ![]() |
![]() |
|||
P2-241 | Incidence of early neonatal hypoglycemia and some related risk factors in Qatar. A cohort study over two years (2018 and 2019) | Noor Hamed | ![]() |
![]() |
|||
P2-242 | Long-term follow-up in a case with congenital hyperinsulinemic hypogliycemia with a novel p.Ser1389Pro mutation in ABCC8 gene | Glin Karacan Kkali | ![]() |
![]() |
|||
P2-243 | Postnatal linear growth and weight gain in infants of non-diabetic mothers (INDM) who were born preterm or near term and had significant neonatal hypoglycemia. | Nada Alaaraj | ![]() |
![]() |
|||
P2-244 | Genetic Testing Access and Results for Patients with Congenital Hyperinsulinism as Conducted through the CHI and University of Exeter Partnership | Tai Pasquini | ![]() |
![]() |
|||
P2-245 | Predictors of short stature in intrauterine growth retardation in a region of north Africa | Bouferoua Fadila | ![]() |
![]() |
|||
P2-246 | Massive Open Online Learning accelerating knowledge in digital health in the management of children with growth disorders | Paul Dimitri | ![]() |
![]() |
|||
P2-247 | A girl with concurrent congenital adrenal hyperplasia, isolated growth hormone deficiency type II (IGHD II) and a new mutation in the GH 1 gene an extremely unusual case | Nora Genthner | ![]() |
![]() |
|||
P2-248 | Reduction in pappalysin and stanniocalcin levels explain the decrease in IGF-I bioavailability in anorexia nervosa | Álvaro Martín-Rivada | ![]() |
![]() |
|||
P2-250 | Patterns of non-adherence to growth hormone treatment in children living in Italy | Chiara Centonze | ![]() |
![]() |
|||
P2-251 | Screening of celiac disease among children with growth hormone deficiency and idiopathic short stature | Amany El-Hawary | ![]() |
![]() |
|||
P2-252 | Pappalysins and stanniocalcins in prenatal and postnatal life | Álvaro Martín-Rivada | ![]() |
![]() |
|||
P2-253 | GROWPATI Study: Growth and puberty description pattern in a well-characterized cohort of patients with growth retardation due to severe primary IGF1 deficiency | Athanasia Stoupa | ![]() |
![]() |
|||
P2-254 | Clinic, laboratory and prognostic findings of patients who are diagnosed by kowarski syndrome (biologically inactive growth hormone) | Mehmet Keskin | ![]() |
![]() |
|||
P2-255 | NadaPrevalence of insulin-like growth factor 1 (IGF1) deficiency in prepubertal children with isolated short stature (ISS) and their response to GH therapy. | Sohair Elsiddig | ![]() |
![]() |
|||
P2-256 | Thyroid function (TF)in short children with idiopathic short stature (ISS) treated with growth hormone (GH)versus those not treated; a controlled study. | Nada Alaaraj | ![]() |
![]() |
|||
P2-257 | Investigating the impact of the TuiTek patient support programme, designed to support caregivers of children prescribed recombinant human growth hormone treatment for growth hormone deficiency in Taiwan: A pilot study | Yen-Fan Lin | ![]() |
![]() |
|||
P2-258 | Incidence of ALS deficiency in patients with growth hormone deficiency at tertiary pediatric endocrinology center | Kamelia Rankova | ![]() |
![]() |
|||
P2-259 | Presentation of IGF-1/IGFBP-3 molar ratio as an effective monitoring index during treatment of growth hormone deficient patients | Kamelia Rankova | ![]() |
![]() |
|||
P2-260 | Current growth hormone therapy practices in Belgium for the treatment of short children born small for gestational age | Muriel Thomas | ![]() |
![]() |
|||
P2-261 | Increased height and IGF1 serum levels in children with non-neurofibromatosis type 1 gliomas | Florencia Clément | ![]() |
![]() |
|||
P2-262 | A Survey on Clinician Perceptions of Long-Acting Growth Hormone Analogs | Naomi Howard-James | ![]() |
![]() |
|||
P2-263 | Pituitary gland volume measured by Magnetic Resonance Imaging as diagnostic predictor of persistent Childhood-onset growth hormone deficiency | Beatriz Corredor-Andres | ![]() |
![]() |
|||
P2-264 | Growth hormone (GH)treatment of children with idiopathic short children (ISS) with normal insulin-like growth factor-1( IGF-1) versus those with low IGF-I at diagnosis. | Sohair Elsiddig | ![]() |
![]() |
|||
P2-265 | Growth response to growth hormone therapy in growth hormone deficient (GHD) children in relation to the distance between their height SDS (HtSDS) and their mid-parental height. | Sohair Elsiddig | ![]() |
![]() |
|||
P2-266 | Linear growth and response to GH therapy in children with short stature with normal Growth hormone secretion: Comparison between children with delayed versus no delay in the bone age at diagnosis. | Nada Alaaraj | ![]() |
![]() |
|||
P2-267 | Linear growth and response to GH therapy in children with GHD with normal IGF-I versus those with normal GH secretion associated with low IGFI at presentation. | Sohair Elsiddig | ![]() |
![]() |
|||
P2-268 | Growth response to growth hormone therapy in short children in relation to their distance from mid-parental heights (MPHt). | Sohair Elsiddig | ![]() |
![]() |
|||
P2-270 | Unified training materials to improve adherence to GH-treatment | Elena Lundberg | ![]() |
![]() |
|||
P2-271 | Linear growth of prepubertal children born small for gestational age on growth hormone therapy for 3 years | Adnan Al Shaikh | ![]() |
![]() |
|||
P2-272 | Evaluation of the clinical and laboratory parameters and final adult height in patients treated with recombinant human growth hormone. | Ayca Altincik | ![]() |
![]() |
|||
P2-273 | THE RESULTS OF TREATMENT WITH GROWTH HORMONE IN A PATIENT WITH GROWTH HORMONE DEFICIENCY AND TYPE 1 DIABETES | Anna Rakus-Kwiatosz | ![]() |
![]() |
|||
P2-274 | Aetiology and different clinical conditions of GHD in children in a region of North Africa | Bouferoua Fadila | ![]() |
![]() |
|||
P2-276 | Growth Hormone Resistance; The Iraqi experience | Ali Al-Jumaili | ![]() |
![]() |
|||
P2-277 | Response to growth hormone therapy with high IGF-1-levels and severe insulin resistance in two-cases with SOFT syndrome: A novel homozygous mutation in POC1A | Esin Karakilic-Ozturan | ![]() |
![]() |
|||
P2-278 | Effects of growth hormone therapy on serum concentrations of IGF-1 in patients with Turner syndrome: High IGF-1 concentrations despite optimal dose? | Esin Karakilic-Ozturan | ![]() |
![]() |
|||
P2-279 | The Effect of Hospital Admission and Nutritional Rehabilitation (NR) on Growth and Metabolic abnormalities in adolescent females with severe Anorexia Nervosa (AN) | Nada Alaaraj | ![]() |
![]() |
|||
P2-280 | Outcomes in growth hormone-treated Noonan syndrome children: impact of PTPN11 mutation status | Alexander Jorge | ![]() |
![]() |
|||
P2-281 | ENDOCRINOLOGICAL ASSESSMENT IN PATIENTS WITH FANCONI ANEMIA | Beatriz Corredor-Andrés | ![]() |
![]() |
|||
P2-282 | Brain-derived neurotrophic factor and matrix metalloproteinases as markers of metabolic status in girls with Turner syndrome. | Ewa Blaszczyk | ![]() |
![]() |
|||
P2-283 | Assessment of genetic defects, baseline characteristics and adverse events reported in the Increlex registry | Amelia Frizell-Armitage | ![]() |
![]() |
|||
P2-284 | Associations between height and health-related quality of life (HRQoL) and functional independence in children with achondroplasia | Melita Irving | ![]() |
![]() |
|||
P2-285 | COVID 19 impact on Pediatric Endocrinology care a short story from Romania | Raluca Pop | ![]() |
![]() |
|||
P2-287 | Novel LZTR1 mutations in subjects with features of Noonan Syndrome and GH insensitivity negatively regulate GH-induced IGF-I production and hyperactivate GH-induced ERK1/2 activation in response to GH in vitro | Sumana Chatterjee | ![]() |
![]() |
|||
P2-288 | COMORBIDITIES IN TURNER SYNDROME PATIENTS CONTROLLED IN OUR CENTER SINCE THE 80s | Raquel Corripio | ![]() |
![]() |
|||
P2-289 | Familial Mosaic Turner Syndrome with short stature and spontaneous puberty due to a ring X chromosome with distal Xp22.3 and distal Xq26 deletion | Sharon Lim | ![]() |
![]() |
|||
P2-290 | Linear growth response to growth hormone therapy in underweight versus normal-weight children with idiopathic short stature (ISS) | Sohair Elsiddig | ![]() |
![]() |
|||
P2-291 | Linear Growth and Weight gain in Infants with Significant Neonatal Hypoglycemia during the first two years of age: Comparison of infants of Diabetic Mothers (IDM) versus infants of non-diabetic mothers (INDM) with transient hyperinsulinemia (non-ketotic) | Nada Alaaraj | ![]() |
![]() |
|||
P2-292 | Timing of infancy-childhood growth spurt in healthy Turkish children | Oya Ercan | ![]() |
![]() |
|||
P2-293 | Effects of GH replacement therapy on body composition and muscle health in children and adolescents with GH deficiency: one-year prospective case-control study. | IMPRODA NICOLA | ![]() |
![]() |
|||
P2-294 | The spectrum of the Prader-Willi-like pheno- and genotype | Alicia Juriaans | ![]() |
![]() |
|||
P2-295 | An Italian survey on GH stimulation tests and their adverse side effects. | Alessandro Salvatoni | ![]() |
![]() |
|||
P2-296 | Comparing the efficacy of nutritional supplementation of different caloric concentrations on linear growth and weight gain in late childhood, a longitudinal study. | Nada Alaaraj | ![]() |
![]() |
|||
P2-297 | The efficacy and safety of recombinant biosimilar growth hormone treatment in children with GHD and SGA: a Czech retrospective national longitudinal study | Marta Snajderova | ![]() |
![]() |
|||
P2-299 | Case report: Tall stature, obesity and hip dysplasia in Weaver syndrome due to a loss-of-function variant in EHZ2 | Niki Paraskevopoulou | ![]() |
![]() |
|||
P2-300 | Association of Daily Growth Hormone Injection Adherence and Height among Children with Growth Hormone Deficiency | Jane Loftus | ![]() |
![]() |
|||
P2-301 | The evaluation of growth velocity, height, weight, elementary laboratory tests and hormonal function in the patient with Floating-Harbor syndrome treated with growth hormone for 20 months case report, preliminary report. | Maja Oko&324;ska | ![]() |
![]() |
|||
P2-302 | Two Sibling Cases with Growth Hormone Receptor Mutation: Variable Clinical Expressivity in Laron Syndrome | Behiye Sar&305;kaya zdemir | ![]() |
![]() |
|||
P2-303 | A literature review of the potency and ivity of FGFR-ive tyrosine kinase inhibitors, such as infigratinib, in the potential treatment of achondroplasia | Lee Miller | ![]() |
![]() |
|||
P2-304 | Impact of estrogen therapy on pubertal growth in Turner syndrome | Marie-Agathe Trouvin | ![]() |
![]() |
|||
P2-305 | ANASTROZOLE IMPROVES HEIGHT PREDICTION AND NEAR FINAL HEIGHT AS MONOTHERAPY OR IN COMBINATION WITH GROWTH HORMONE | Renata Machado Pinto | ![]() |
![]() |
|||
P2-306 | Growth hormone deficiency (GHD) with high circulating insulin-like growth factor-1 (IGF-1) in an adolescent with celiac disease: Is it IGF-1 insensitivity? | Nada Alaaraj | ![]() |
![]() |
|||
P2-307 | Postnatal Linear Growth and Weight Gain in Infants of Diabetic Mothers (IDM) Who Were Born at or Near Term and Had Severe Neonatal Hypoglycemia Without Other Comorbidities. | Nada Alaaraj | ![]() |
![]() |
|||
P2-308 | Evidence that non-syndromic familial tall stature has an oligogenic origin including ciliary genes | Gudrun A. Rappold | ![]() |
![]() |
|||
P2-309 | Early-onset growth hormone treatment in Prader-Willi syndrome attenuates the risk of transition to severe obesity | Aneta Kodytková | ![]() |
![]() |
|||
P2-310 | Incidental pituitary adenoma detection in two patients affected by Williams Syndrome: only a coincidence? | Silvia Ciancia | ![]() |
![]() |
|||
P2-311 | Efficacy of recombinant growth hormone therapy in TRPS 1 syndrome coexisting with growth hormone deficiency. | Kamil Dyrka | ![]() |
![]() |
|||
P2-312 | Results from the Implementation of a Growth Disorders Related Twinning Programme (Partners4Growth) at tertiary pediatric endocrinology clinics | Stanimira Elkina | ![]() |
![]() |
|||
P2-313 | CO-OCCURRENCE OF TURNER (46,X-ring/45,X0 MOSAICISM) AND MAYER-ROKITANSKY-KUSTER-HAUSER SYNDROMES: A CASE REPORT. | Laura Ocello | ![]() |
![]() |
|||
P2-314 | Shox Gene Pathologies In Children With Short Stature And Madelung Deformity | Merve Sakar | ![]() |
![]() |
|||
P2-315 | Characteristics of Patients with Noonan Syndrome Carrying a PTPN11 Mutation: The Recombinant Growth Hormone Treatment and Long-Term Follow-up | Glin Karacan Kkali | ![]() |
![]() |
|||
P2-316 | DETERMINING FACTORS OF A GOOD RESPONSE TO TREATMENT WITH GROWTH HORMONE FOR THE FIRST 2 YEARS | Antonio de Arriba | ![]() |
![]() |
|||
P2-317 | Noonan syndrome patients with short stature at a single pediatric endocrinology centre | Yana Deyanova | ![]() |
![]() |
|||
P2-319 | Rare case report: A Chinese boy with MDPL syndrome cause by POLD1 gene mutation | Qiuli Chen | ![]() |
![]() |
|||
P2-320 | An Unusual Case of Gastrointestinal Bleeding: Expecting the Unexpected | Sarah Brooke | ![]() |
![]() |
|||
P2-321 | Alterations in Metabolic profile and Body Composition in children with Silver Russell syndrome | GIUSEPPA PATTI | ![]() |
![]() |
|||
P2-322 | Growth abnormalities in patients with Type 1 diabetes | Najoua MESSAOUDI | ![]() |
![]() |
|||
P2-323 | A novel CEP57 mutation of mosaic variegated aneuploidy syndrome in a Chinese girl:a case report and review of literature | Biyun feng | ![]() |
![]() |
|||
P2-324 | A Patient with Turner Syndrome (45X/46XX) and Congenital Adrenal Hyperplasia: A Case Report and Literature Review | yirou wang | ![]() |
![]() |
|||
P2-325 | Impact of oral nutritional supplements on growth outcomes in underweight children (5: 12 years) with no systemic disease. | Nada Alaaraj | ![]() |
![]() |
|||
P2-326 | Differential diagnosis of pre- and postnatal short stature revisited: 3-M syndrome | Platonas Karatsiolis | ![]() |
![]() |
|||
P2-327 | A case of a Floating-Harbor syndrome in a child with severe short stature. | Anna Prosvirnina | ![]() |
![]() |
|||
P2-328 | Excessive body hair, short stature and advanced bone age in a girl : Hypertrichosis versus adrenarche? | Shayma Ahmed | ![]() |
![]() |
|||
P2-329 | CORNELIA DE LANGE SYNDROME: A CASE REPORT | Marouan Karrou | ![]() |
![]() |
|||
P2-330 | Short stature and efficacy of growth hormone treatment in a child with Nail-Patella Syndrome. A case report. | Maria Pankratova | ![]() |
![]() |
|||
P2-331 | Final and Near-final Adult Height and BMI after Long-term Growth Hormone Treatment in Patients with Turner Syndrome (TS) | Adnan Al Shaik | ![]() |
![]() |
|||
P2-332 | Evaluating Safety, Efficacy, and Pharmacokinetics of Weekly TransCon CNP in Children with Achondroplasia: Design of the ACcomplisH Trial | Ciara Mcdonnell | ![]() |
![]() |
|||
P2-333 | An Early Diagnosis of Prohormone Convertase Deficiency | Selin Elmaogullari | ![]() |
![]() |
|||
P2-334 | Serologic Testing for Celiac Disease and Gluten Intolerance in a Singaporean paediatric endocrine and growth clinic. | Warren Lee | ![]() |
![]() |
|||
P2-335 | Obesity, vaginal bleeding and ovarian mass in a 5-year-old female girl with autoimmune hypothyroidism | Shaymaa Elsayed | ![]() |
![]() |
|||
P2-336 | Endocrine and metabolic complications according to genotype in Prader-Willi syndrome | Ju Young Yoon | ![]() |
![]() |
|||
P2-337 | Van Wyk-Grumbach Syndrome in an Egyptian Female Pediatric Patient: a rare presentation of a common disease | Amany Ibrahim | ![]() |
![]() |
|||
P2-338 | Diagnostic and Follow-up Problems of Medical Care for Prader-Willi Syndrome Children in Resourse-Limited Settings | Natallia Akulevich | ![]() |
![]() |
|||
P2-339 | THREE GENERATIONS OF MEN-1: THE IMPORTANCE OF FAMILY SCREENING | Julia Galhardo | ![]() |
![]() |
|||
P2-340 | Follow-up and management of endocrine and metabolic disorders after hematopoietic stem cell transplantation in a patient followed for Fanconi anemia | Najoua Lassoued | ![]() |
![]() |
|||
P2-341 | Neonatal McCune Albright Syndrome Presenting with Diabetes Mellitus | Yagmur nsal | ![]() |
![]() |
|||
P2-342 | Combined pituitary hormone deficiency associated with Graves disease | Najoua Lassoued | ![]() |
![]() |
|||
P2-343 | Autoimmune polyendocrine syndrome type 2 and precocious puberty: a rare association | Imane Assarrar | ![]() |
![]() |
|||
P2-344 | Thermoregulatory delays in Greek PCOS adolescents | Flora Bacopoulou | ![]() |
![]() |
|||
P2-345 | Endocrine manifestations in familial neurofibromatosis type 1: a case report | Younes Ayadi | ![]() |
![]() |
|||
P2-346 | The clinical and biochemical spectrum of pituitary lesions in children compared to adults: experience from a single tertiary center | Elena Galazzi | ![]() |
![]() |
|||
P2-347 | Optic tract glioma and endocrine disorders- comparison between patients with and without NF1- a single center experience | Merav Gil Margolis | ![]() |
![]() |
|||
P2-348 | ENDOCRINE MANIFESTATIONS OF PAEDIATRIC INTRACRANIAL GERM CELL TUMOUR: FROM DIAGNOSIS TO LONG-TERM FOLLOW-UP | Cristina Partenope | ![]() |
![]() |
|||
P2-349 | Machine learning to detect the Klinefelter syndrome endocrine profile | André Madsen | ![]() |
![]() |
|||
P2-350 | Nuchal Skinfold Thickness in Pediatric Brain Tumor Patients | Hermann L. Mller | ![]() |
![]() |
|||
P2-351 | Growth hormone deficiency in 52 children with brain Magnetic Resonance Imaging Abnormalities | OUIDAD BAZ | ![]() |
![]() |
|||
P2-352 | Patients with PWS and related syndromes display differentially methylated regions involved in neurodevelopmental and nutritional trajectory. | Juliette Salles | ![]() |
![]() |
|||
P2-353 | CLINICAL COURSE OF PRIMARY EMPTY SELLA IN CHILDREN: A 10-YEAR SINGLE-CENTER EXPERIENCE | Ozge Besci | ![]() |
![]() |
|||
P2-354 | Relation between specific pubertal growth and breast maturation - a longitudinal study in healthy girls | Sophie Bergendahl | ![]() |
![]() |
|||
P2-355 | Did Central Precocious Puberty Increase in COVID 19 Pandemic? | Burce Orman | ![]() |
![]() |
|||
P2-356 | DELAYED DIAGNOSIS OF PAEDIATRIC INTRACRANIAL GERM CELL TUMOUR (IC-GCTs) | Cristina Partenope | ![]() |
![]() |
|||
P2-357 | Gonadotropin-releasing hormone analog treatment in children with idiopathic central precocious puberty: a pharmacovigilance study in a pediatric population. | Chiara Nasso | ![]() |
![]() |
|||
P2-358 | Pubertal induction in girls with hypogonadism: preliminary prospective data of efficacy in patients with/without initial overnight estrogen replacement | Giulia Rodari | ![]() |
![]() |
|||
P2-359 | EVALUATION OF PITUITARY/CRANIAL IMAGING RESULTS OF CENTRAL PUBERTE PRECOCIOUS CASES | Havva Nur Peltek Kendirci | ![]() |
![]() |
|||
P2-360 | In vivo magnetic resonance spectroscopy as a non-invasive tool for the identification of a sellar tumour in a boy with precocious puberty. | Ioanna Kosteria | ![]() |
![]() |
|||
P2-361 | Rahman Syndrome: Hypopituitarism might be responsible for changing height pattern | Sare Kaygusuz | ![]() |
![]() |
|||
P2-362 | CONGENITAL HYPOPITUITARISM: THE ROLE OF GENETICS | Estela Gil Poch | ![]() |
![]() |
|||
P2-363 | Pedigree analysis is essential for clarifying oligogenic transmission in a family with congenital hypogonadotropic hypogonadism (CHH) | Sarah Oberhauser | ![]() |
![]() |
|||
P2-364 | Congenital hypogonadotropic hypogonadism associated with X-linked ichthyosis due to X-chromosome microdeletion identified by chromosomal microarray | Kristina Kokoreva | ![]() |
![]() |
|||
P2-365 | Gonadotropin Flare with Different Depot GnRH Agonists: Comparative Analysis. | Analía Freire | ![]() |
![]() |
|||
P2-366 | HYPOTHALAMIC OBESITY IN CHILDREN WITH CRANIOPHARYNGIOMA | Ouidad Baz | ![]() |
![]() |
|||
P2-367 | Duplication of Pituitary Gland-plus Syndrome presenting with a Transcranial Nasal Dermoid Cyst | Manju Chandwani | ![]() |
![]() |
|||
P2-368 | Sterile Abscess Formation with Two Different GnRH Analogues: Three Case Reports | Glin Karacan Kkali | ![]() |
![]() |
|||
P2-369 | 6-Month GnRHa Formulations Are a Good Choice During the COVID-19 Pandemic and Beyond | Matthew Benson | ![]() |
![]() |
|||
P2-370 | Size Matters: CAG Repeat Length of the Androgen Receptor Gene, Testosterone, and Male Adolescent Depression Severity | Raphael Hirtz | ![]() |
![]() |
|||
P2-371 | Is quail egg a potential endocrine disrupter ? | Sare Kaygusuz | ![]() |
![]() |
|||
P2-372 | The impact of the Covid-19 pandemic on the UK National Hypothalamic-pituitary Axis Tumour (HPAT) multidisciplinary meeting | Laura Bosch i Ara | ![]() |
![]() |
|||
P2-373 | Evaluation of Clinical, Laboratory and Radiological Findings in the Differential Diagnosis of Premature Telarche and Central Puberty Precocious | Havva Nur Peltek Kendirci | ![]() |
![]() |
|||
P2-374 | Crooke Cell Adenoma as a Rare Cause of Recurrent Cushing Disease: A Challenge in Treatment and Follow-up | Arzu Jalilova | ![]() |
![]() |
|||
P2-375 | Salivary sex steroids as markers of puberty in boys during late childhood and adolescence | Supitcha Patjamontri | ![]() |
![]() |
|||
P2-376 | Efficacy of cabergoline in the treatment of pituitary macroadenoma complicated in a 14-year-old girl. | Anouar Jamal | ![]() |
![]() |
|||
P2-377 | USE OF TOLVAPTAN IN A CHILD WITH SIADH POST PITUITARY SURGERY | Nikhil Lohiya | ![]() |
![]() |
|||
P2-378 | The effect of 3 years of Gonadotropin-Suppressive Therapy in Girls with Early Puberty: Height Z Score in Relation to Mid-Parental height Z score. | Nada Alaaraj | ![]() |
![]() |
|||
P2-379 | An Observational, Retrospective Study to Evaluate Long Term Safety and Effectiveness of Leuprorelin in the Treatment of Central Precocious Puberty | Junfen Fu | ![]() |
![]() |
|||
P2-381 | Characterization of puberty development in a large cohort of patients with Noonan syndrome with molecular diagnosis | Raíssa Rezende | ![]() |
![]() |
|||
P2-382 | Pituitary tumors in children and adolescents: clinical and etiological profile | Nisrine Bouichrat | ![]() |
![]() |
|||
P2-383 | Langerhans Cell Histiocytosis with Isolated Central Diabetes Insipidus, Low Grade Fever and Sellar Erosion | Iclal Okur | ![]() |
![]() |
|||
P2-384 | Basal LH as a screening test for diagnosis of central precocious puberty | Shaymaa Raafat Mahfouz | ![]() |
![]() |
|||
P2-386 | Blood Pressure in Girls with Central Precocious Puberty and GnRH Analog Therapy | Naama Fisch Shvalb | ![]() |
![]() |
|||
P2-387 | Isolated central diabetes insipidus and periventricular nodular heterotopia in a 9-year-old girl | Florentina Haufler | ![]() |
![]() |
|||
P2-388 | Central precocious puberty: clinical, etiologic and therapeutic features | Imane Assarrar | ![]() |
![]() |
|||
P2-389 | Atypical Presentation of Pituitary Macroadenoma in an adolescent girl: Central Hypothyroidism and Attenuated Pubertal Growth Spurt. | Nada Alaaraj | ![]() |
![]() |
|||
P2-390 | A case of partially Empty Sella with hypopituitarism in a child | Rajat Pratap | ![]() |
![]() |
|||
P2-391 | Cushings disease in paediatric patients: Diagnosis and evolution | Najoua MESSAOUDI | ![]() |
![]() |
|||
P2-393 | First Morning Voided Urinary Gonadotropin Measurements for the Early Screening, Diagnosis and Follow-up of Central Precocious Puberty Patients | Feng Ye | ![]() |
![]() |
|||
P2-395 | Cognitive function and linear growth in Prednisone -treated children with salt-wasting congenital adrenal hyperplasia | Shaymaa Elsayed | ![]() |
![]() |
|||
P2-396 | Combining big data science with clinics: Novel approach for understanding human sex development and its variants. | Daniel Rodríguez Gutiérrez | ![]() |
![]() |
|||
P2-397 | Vascular dysfunction and increased cardiovascular risk in hypospadias | Angela Lucas-Herald | ![]() |
![]() |
|||
P2-399 | Self-reported Feelings of Adult Patients with Differences of Sex Development (DSD) Regarding Genital Surgical Procedures | Berenice Bilharinho de Mendonca | ![]() |
![]() |
|||
P2-401 | TWO SISTERS WITH PRIMARY HYPERGONADOTROPIC HYPOGONADISM, PUBERTAL PROGRESS AND DELETION OF 61.5MB OF Xq21.33q28 REGION | Eirini Dikaiakou | ![]() |
![]() |
|||
P2-402 | DESCRIPTION OF A NEW VARIANT IN THE MAMLD1 GENE IN AN INFANT WITH MICROPHALLUS AND HYPOSPADIAS | Cristina Aguilar Riera | ![]() |
![]() |
|||
P2-403 | SURGICAL ASPECTS OF THE MULTICENTRIC AND INTERDISCIPLINARY STUDY IN MINORS WITH DIFFERENT SEXUAL DEVELOPMENT | Ignacio Diez-Lopez | ![]() |
![]() |
|||
P2-404 | Is Inflammation the Major Driver of Polycystic Ovary Syndrome (PCOS)? A Proteomic Approach to Understanding PCOS in Adolescents and the Search for Novel Non-Invasive Biomarkers | Harriet Gunn | ![]() |
![]() |
|||
P2-405 | Serum High Mobility Group Box 1 (HMGB1) levels are independently associated with glucose clamp-derived measures of insulin resistance in PCOS. | Maria Elisabeth Street | ![]() |
![]() |
|||
P2-406 | ZSWIM7 is associated with human female meiosis and familial primary ovarian insufficiency | Sinead McGlacken-Byrne | ![]() |
![]() |
|||
P2-407 | IS THE RECOMMENDED DUAL THERAPY FOR TRANSSEXUAL BOYS HARMLESS? | Itxaso Rica | ![]() |
![]() |
|||
P2-408 | Plexiform neurofibroma of the penis as an infrequent manifestation debut in a pediatric patient. | Fernanda Peńa | ![]() |
![]() |
|||
P2-409 | Surprising X Chromosomes: Unusual Mosaicism | Zeinab Zorkot | ![]() |
![]() |
|||
P2-410 | Puberty delay in girls: etiological structure of the disease | Kseniya Kabolova | ![]() |
![]() |
|||
P2-411 | Rationale for a reduced dexamethasone dose in prenatal congenital adrenal hyperplasia therapy based on pharmacokinetic modelling | Uta Neumann | ![]() |
![]() |
|||
P2-412 | 45,X/46,XY Mosaicism: Phenotypic characteristics, Growth, and Gonadal features. | Nalini M Selveindran | ![]() |
![]() |
|||
P2-413 | Challenges faced by children and adolescents with Differences in Sex Development (DSD) managed at a tertiary care specialized university center in Sri Lanka. | Chamath Jayakody | ![]() |
![]() |
|||
P2-414 | A novel mutation of SOX2 gene in an idiopathic hypogonadotropic hypogonadism patient with olfactory bulb agenesis | yijun tang | ![]() |
![]() |
|||
P2-415 | Obesity, ovarian mass, vaginal bleeding and hypothyroidism in a 5-year-old female girl | Noora Alhemaidi | ![]() |
![]() |
|||
P2-416 | Ovarian Juvenile Granulosa Cell Tumor in 9-Month-Old female Infant presented with Isosexual Pseudo Puberty: Case Report | Shayma Ahmed | ![]() |
![]() |
|||
P2-417 | A case report of Non-syndromic 46, XX testicular DSD presenting as a genital ambiguity - Clinical, molecular and cytogenetic analysis | kishore behera | ![]() |
![]() |
|||
P2-419 | A late revelation of Sexual differentiation disorder 46XX due to 11 beta hydroxylase deficiency | Khensal Sabrina | ![]() |
![]() |
|||
P2-421 | Radiological evaluation of children with atypical genitalia due to disorders of sex development (46, XY DSD) in a resource-limited setup | Doaa Khater | ![]() |
![]() |
|||
P2-422 | 17 HYDROXYLASE DEFICIENCY AND DIABETES IN A CASE WITH 46 XY FEMALE | Ahmet Yildirim | ![]() |
![]() |
|||
P2-423 | Diagnostic Dilemma in a Patient with Central Precocious Puberty: Ovarian Steroid Cell Tumor | Hanife Gl Balki | ![]() |
![]() |
|||
P2-424 | Dimensional approach to Gender Dysphoria in Nigeria: association with socio-demographics and psycho-sexual variables. | Ugo Chikani | ![]() |
![]() |
|||
P2-425 | Puberty delay in girls: analyses of disease structure depending on clinical characteristics | Kseniya Kabolova | ![]() |
![]() |
|||
P2-426 | UTERUS AGENESIA IN A PATIENT WITH CATCH 22 SYNDROME. PURPOSE OF A CASE. | Ignacio Diez-Lopez | ![]() |
![]() |
|||
P2-427 | High throughput screening of DSD candidate genes with the help of the powerful model Drosophila melanogaster | Isabel von der Decken | ![]() |
![]() |
|||
P2-428 | Case series: Use of tamoxifen in the management of gynaecomastia in three adolescent boys with 46 XY DSD | Chamath Jayakody | ![]() |
![]() |
|||
P2-429 | 4-year-old female patient with mixed germ cell tumor and underlying Cowden syndrome | Daniela Habacht | ![]() |
![]() |
|||
P2-430 | A COMPARISON BETWEEN ANDROSTANOLONE AND TESTOSTERONE ENANTHATE FOR PENILE AUGMENTATION IN PATIENTS WITH IDIOPATHIC MICROPENIS | Marouan Karrou | ![]() |
![]() |
|||
P2-431 | Combination therapy of hypogonadotropic hypogonadism with rFSH and hCG case report | Kristina Kokoreva | ![]() |
![]() |
|||
P2-432 | 46,XY DSD due to biallelic DHX37 gene mutations | Mehmet Eltan | ![]() |
![]() |
|||
P2-433 | Novel Mutation in an Iranian Family with 17- Hydroxysteroid Dehydrogenase Type 3 Deficiency | Fatemeh Saffari | ![]() |
![]() |
|||
P2-434 | A CASE OF GENDER DEVELOPMENTAL DISORDER WITH DIFFICULTY IN MOLECULAR DIAGNOSIS: NEW VARIANT IN NR5A1 GENE | Emrullah Arslan | ![]() |
![]() |
|||
P2-435 | Two pedigrees with congenital bilateral anorchia in one sibling and testicular torsion at adolescence in another: a shared genetic predisposition? | Cécile Brachet | ![]() |
![]() |
|||
P2-436 | Importance of testicular biopsy for validation of diagnosis; cryptorchidism, analyzing prescrotal undescended testes | Faruk Hadziselimovic | ![]() |
![]() |
|||
P2-437 | Rare Genetic disorder associated with microphallus | Khalid Khan | ![]() |
![]() |
|||
P2-438 | CONGENITAL ADRENAL HYPERPLASIA IN DETAIL: A MULTICENTRIC AND INTERDISCIPLINARY STUDY IN MINORS WITH DIFFERENT SEXUAL DEVELOPMENT | Ignacio Diez-Lopez | ![]() |
![]() |
|||
P2-439 | SEX ASSIGNMENT AT BIRTH: IS IT ALWAYS EASY? | Marouan Karrou | ![]() |
![]() |
|||
P2-440 | Combination therapy of hypogonadotropic hypogonadism in boys with rFSH and hCG case reports analyses | Kristina Kokoreva | ![]() |
![]() |
|||
P2-441 | Clinical case of premature ovarian failure in combination with blepharophimosis-ptosis-epicanthus inversus due to mutation in FOXL2 gene | Sofia Enikeeva | ![]() |
![]() |
|||
P2-442 | Persistent Mllerian duct syndrome presenting with bilateral cryptorchidism and obstructed inguinal hernia. | Anatoli Fotiadou | ![]() |
![]() |
|||
P2-443 | 5 ALPHA REDUCTASE TYPE 2 DEFICIENCY: A CASE REPORT | Marouan Karrou | ![]() |
![]() |
|||
P2-445 | Could intramuscular testosterone differentiate between partial androgen insensitivity and 5 alpha reductase type 2 deficiency? | Shaymaa Raafat | ![]() |
![]() |
|||
P2-446 | The efficacy and short- and long-term side effects of radioactive iodine treatment in pediatric Graves disease: a systematic review | Christiaan Mooij | ![]() |
![]() |
|||
P2-447 | Incidentally detected papillary thyroid cancer with elevated calcitonin in a 15 year-old female : a case report | Jeesuk Yu | ![]() |
![]() |
|||
P2-448 | Methimazole-Induced Remission Rates in Pediatric Graves Disease: a Systematic Review | Nitash Zwaveling-Soonawala | ![]() |
![]() |
|||
P2-449 | Congenital multinodular goiter causing acute airway obstruction in a newborn: a case report | Mirjam Scheffer-Rath | ![]() |
![]() |
|||
P2-450 | Initial response to thionamide medication in young people with newly diagnosed thyrotoxicosis. | Claire Wood | ![]() |
![]() |
|||
P2-451 | A GIRL WITH TRISOMY 21 PRESENTS WITH VAN WYK-GRUMBACH SYNDROME. A RARE DIAGNOSIS | Ioanna Kosteria | ![]() |
![]() |
|||
P2-452 | Complications after pediatric thyroidectomy: lymph node dissection is a risk factor for permanent hypocalcemia | Christiaan Mooij | ![]() |
![]() |
|||
P2-453 | Kinetics of FT4 serum concentrations in newborns and infants with congenital hypothyroidism during follow-up differ in the three severity groups | Britta Steffens | ![]() |
![]() |
|||
P2-455 | Expression of Zinc transporter 8 in thyroid tissues from patient with immune and non-immune thyroid diseases. | Artur Bossowski | ![]() |
![]() |
|||
P2-456 | HASHIMOTO THYROIDITIS: LONG TERM FOLLOW-UP FROM CHILDHOOD TO YOUNG ADULTHOOD | Francesco David | ![]() |
![]() |
|||
P2-457 | A case of complete atrioventricular block after initiation of methimazole in a patient with Graves disease associated with Downs syndrome previously undergoing cardiac surgery | KENTARO SAWANO | ![]() |
![]() |
|||
P2-458 | UNILATERAL AUTOIMMUNE OPHTHALMOPATHY AS A FIRST SYMPTOM IN MANIFESTATION OF AUTOIMMUNE THYROIDITIS AND SYSTEMIC LUPUS ERYTHEMATOSUS IN AN ADOLESCENT GIRL.CASE REPORT. | Olena Tolstikova | ![]() |
![]() |
|||
P2-459 | Incidence and etiology of primary congenital hypothyroidism in Flanders | Sofie Ryckx | ![]() |
![]() |
|||
P2-460 | Re-evaluation of the prevalence of permanent congenital hypothyroidism in Niigata, Japan: A retrospective study | Keisuke Nagasaki | ![]() |
![]() |
|||
P2-461 | EARLY REASSESSMENT IN CONGENITAL HYPOTHYROIDISM | Gema Grau | ![]() |
![]() |
|||
P2-462 | Growth impairment in children with severe autoimmune primary hypothyroidism and pituitary hyperplasia without goiter. | Domenico Corica | ![]() |
![]() |
|||
P2-463 | The Use Of Intravenous Introduction Of Glucocorticoids In The Active Stage Of Graves Ophthalmopathy In Childhood. Clinical Case. | Tatiana Ivannikova | ![]() |
![]() |
|||
P2-464 | Atypical presentation of acute suppurative thyroiditis in a 6 year old child. | Maria Liapi | ![]() |
![]() |
|||
P2-465 | Allan-Herndon-Dudley syndrome: case report of a rare disorder | Irina Muradyan | ![]() |
![]() |
|||
P2-466 | Hypothyroidism in context of 1q44 microdeletion syndrome and DOLK-CDG | Bogdan Pascu | ![]() |
![]() |
|||
P2-467 | Graves Ophthalmopathy in Pediatric Age: Different Severities, Different Approaches | David Veríssimo | ![]() |
![]() |
|||
P2-469 | Thyroid dysfunction in Beta-thalassemia patients | Noumi Mustapha | ![]() |
![]() |
|||
P2-470 | VICTIM PATHOLOGIES OF THE PANDEMIC. SEVERE ACQUIRED HYPOTHYROIDISM. | Ignacio Diez-Lopez | ![]() |
![]() |
|||
P2-471 | Mitigating thyroid cancer risk in multinodular hyperplasia secondary to a 10q23.31 deletion (PTEN Hamartoma Tumour Syndrome) | Meera Shaunak | ![]() |
![]() |
|||
P2-472 | Thyroid dysfunction and autoimmune thyroiditis in children with new-onset diabetes mellitus | Jeesuk Yu | ![]() |
![]() |
|||
P2-473 | A Rare Cause of Congenital Hypothyroidism: Brain-Lung-Thyroid Syndrome | Aslihan Arasli Yilmaz | ![]() |
![]() |
|||
P2-474 | Recurrent fractures in a child with Graves disease | Fatih Kilci | ![]() |
![]() |
|||
P2-475 | Case study of 13- year-old boy suffering from papillary thyroid cancer in stage pT3aN1bMX. | Artur Bossowski | ![]() |
![]() |
|||
P2-476 | EVALUATION OF GENERAL CHARACTERISTICS OF CHILDREN WITH HYPOTHYROIDI | Beray Selver Eklioglu | ![]() |
![]() |
|||
P2-477 | L-T4 absorption test in 14-year-old patient with severe refractory hypothyroidism after total thyroidectomy | Gaia Vincenzi | ![]() |
![]() |
|||
P2-478 | A child with anti-thyroid arthritis syndrome | Fatih Kilci | ![]() |
![]() |
|||
P2-479 | Thyroglobulin deficiency: a rare cause of neonatal stridor | Xanthippi Tseretopoulou | ![]() |
![]() |
|||
P2-480 | TBG deficiency and Central Congenital Hypothyroidism (CCH): Our experience in neonatal screening with TSH and T4 | Maria J. Chueca | ![]() |
![]() |
|||
P2-481 | A CASE OF HYPOTHYROIDISM POST BONE MARROW TRANSPLANTATION | Ouidad Baz | ![]() |
![]() |
|||
P2-485 | Prevalence and associated factors of Congenital Hypothyroidism in Bogotá, Colombia. 2014 - 2020 | Pablo Pineda | ![]() |
![]() |
|||
P2-486 | Aetiology and different clinical condition of hypothyroidism in children and adolescents | Fadila Bouferoua | ![]() |
![]() |
|||
P2-487 | Influenza A induced Thyrotoxic Storm Post Haematopoietic Stem Cell Transplantation | Nuthana Prathivadi Bhayankaram | ![]() |
![]() |
|||
P2-489 | Thyrotropic cell hyperplasia secondary to prolonged uncontrolled primary hypothyroidism | Ana Belen Ariza Jimenez | ![]() |
![]() |
|||
P2-490 | Thyroid dyshormonogenesis: a case report of two siblings with a heterozygous variant in the TPO gene. | Tatiana Vadina | ![]() |
![]() |
|||
P2-491 | Pediatric Graves disease in southern Tunisia | Sana Kmiha | ![]() |
![]() |
22-26 September 2021 Virtual Conference
![]() |
Digital Object Identifier. Official code used to identify documents published on internet; similar to ISBN for books. You may use this code to reference your poster in future scientific publications or CVs. It can be found from anywhere in the world. ![]() To find the poster page, log onto www.medra.org and enter the DOI, or enter in your internet browser https://dx.doi.org/ followed by the DOI string asigned to your congress. ![]() |
![]() |
||
![]() |
|